Patent application title: METHOD FOR PRODUCING PROTEIN COMPOSITION, AND PROTEIN COMPOSITION
Inventors:
IPC8 Class: AA61L208FI
USPC Class:
1 1
Class name:
Publication date: 2018-03-01
Patent application number: 20180055958
Abstract:
The present invention aims to provide a method for producing a protein
composition, the method being capable of suppressing changes such as
degradation and denaturation of a protein which occur when a highly
hydrophilic protein or a protein that undergoes denaturation by complete
removal of water is irradiated with radiation. The present invention
provides a method for producing a protein composition containing a
protein (A), a radical scavenger (RS), and at least one
hydrogen-bond-formable compound (HC) selected from the group consisting
of amino acids, peptides, and proteins other than the protein (A), the
method including a sterilization step of radiosterilizing an unsterilized
protein composition, wherein the unsterilized protein composition
contains the protein (A), the radical scavenger (RS), and the
hydrogen-bond-formable compound (HC), the protein (A) contains at least
one functional group selected from the group consisting of sulfide,
amide, hydroxyl, amino, and carboxyl groups, the hydrogen-bond-formable
compound (HC) contains at least one functional group selected from the
group consisting of sulfide, amide, hydroxyl, amino, and carboxyl groups,
the at least one functional group in the protein (A) is capable of
binding to the at least one functional group in the
hydrogen-bond-formable compound (HC) via a hydrogen bond, the
unsterilized protein composition has a water content of 0 to 30% by
weight based on the weight of the unsterilized protein composition, a
weight ratio of the radical scavenger (RS) to the protein (A) in the
unsterilized protein composition [radical scavenger (RS)/protein (A)] is
0.01 to 1.0, and a molar ratio of a total molar number of functional
groups in the hydrogen-bond-formable compound (HC) to a total molar
number of functional groups in the protein (A) in the unsterilized
protein composition [the total molar number of functional groups in the
hydrogen-bond-formable compound (HC)/the total molar number of functional
groups in the protein (A)] is 0.01 to 0.50.Claims:
1. A method for producing a protein composition containing a protein (A),
a radical scavenger (RS), and at least one hydrogen-bond-formable
compound (HC) selected from the group consisting of amino acids,
peptides, and proteins other than the protein (A), the method comprising:
a sterilization step of radiosterilizing an unsterilized protein
composition, wherein the unsterilized protein composition contains the
protein (A), the radical scavenger (RS), and the hydrogen-bond-formable
compound (HC), the protein (A) contains at least one functional group
selected from the group consisting of sulfide, amide, hydroxyl, amino,
and carboxyl groups, the hydrogen-bond-formable compound (HC) contains at
least one functional group selected from the group consisting of sulfide,
amide, hydroxyl, amino, and carboxyl groups, the at least one functional
group in the protein (A) is capable of binding to the at least one
functional group in the hydrogen-bond-formable compound (HC) via a
hydrogen bond, the unsterilized protein composition has a water content
of 0 to 30% by weight based on the weight of the unsterilized protein
composition, a weight ratio of the radical scavenger (RS) to the protein
(A) in the unsterilized protein composition [radical scavenger
(RS)/protein (A)] is 0.01 to 1.0, and a molar ratio of a total molar
number of functional groups in the hydrogen-bond-formable compound (HC)
to a total molar number of functional groups in the protein (A) in the
unsterilized protein composition [the total molar number of functional
groups in the hydrogen-bond-formable compound (HC)/the total molar number
of functional groups in the protein (A)] is 0.01 to 0.50.
2. The method for producing a protein composition according to claim 1, wherein in the unsterilized protein composition, the at least one functional group of the protein (A) is on a side chain of an amino acid, the at least one functional group on a side chain of an amino acid in the protein (A) is capable of binding to the at least one functional group in the hydrogen-bond-formable compound (HC) via a first hydrogen bond, and the first hydrogen bond has a distance of 1.3 to 1.9 .ANG..
3. The method for producing a protein composition according to claim 1, wherein in the unsterilized protein composition, the at least one functional group in the protein (A) is an amide group in a peptide bond in the protein (A), the amide group in a peptide bond in the protein (A) is bound to the hydrogen-bond-formable compound (HC) via a second hydrogen bond, and the second hydrogen bond has a distance of 1.3 to 1.9 .ANG..
4. The method for producing a protein composition according to claim 1, wherein the amino acid composition of the protein (A) is such that the number of proline (P) residues accounts for 1 to 50%, the number of serine (S) residues accounts for 1 to 50%, and the number of valine (V) residues accounts for 1 to 50%, based on the total number of amino acids in the protein (A).
5. The method for producing a protein composition according to claim 1, wherein the protein (A) contains a repetitive sequence (X).
6. The method for producing a protein composition according to claim 5, wherein the repetitive sequence (X) includes any one amino acid sequence (a1) selected from the group consisting of GAGAGS (1), RGD, YIGSR (2), GVGVP (3), PGVGV (4), VPGVG (5), GVPGV (6), VGVPG (7), GPP, GAP, GAHGPAGPK (8), GAA, VAAGY (9), GAGAGAS (10), LGPLGP (11), GAHGPAGPK (12), GAPGPAGPPGSRGDPGPP (13), GAQGPAGPG (14), GAPGAPGSQGAPGLQ (15), GAPGTPGPQGLPGSP (16), GAAVTGRGDSPASAAGY (17), and GAAPGASIKVAVSAGPSAGY (18).
7. The method for producing a protein composition according to claim 5, wherein the repetitive sequence (X) includes an amino acid sequence consisting of 2 to 200 repeats of GAGAGS (1).
8. The method for producing a protein composition according to claim 5, wherein the repetitive sequence (X) includes a sequence (Y) consisting of 2 to 200 repeats of an amino acid sequence (a2) that is one of GVGVP (3), PGVGV (4), VPGVG (5), GVPGV (6), VGVPG (7), GPP, GAP, or GAHGPAGPK (8) and/or a sequence (Y1) in which 1 to 100 amino acids in the sequence (Y) are replaced by lysine (K) or arginine (R).
9. The method for producing a protein composition according to claim 8, wherein a ratio of a number of units of GAGAGS (1) to a total number of the amino acid sequences (a2) and amino acid sequences (a2') described below in one molecule of the protein (A) [(the number of units of GAGAGS (1)):(the total number of the amino acid sequences (a2) and (a2'))] is [1:2] to [1:20], amino acid sequence (a2'): an amino acid sequence in which one to five amino acids in the amino acid sequence (a2) are replaced by lysine (K) or arginine (R).
10. The method for producing a protein composition according to claim 5, wherein the repetitive sequence (X) includes a sequence (Y2) consisting of 1 to 50 repeats of an amino acid sequence (a3) that is one of GAAVTGRGDSPASAAGY (17) or GAAPGASIKVAVSAGPSAGY (18).
11. The method for producing a protein composition according to claim 1, wherein the protein (A) has a molecular mass of 15 to 200 kDa as determined by SDS-polyacrylamide gel electrophoresis.
12. The method for producing a protein composition according to claim 1, wherein the radical scavenger (RS) has a structure that is at least one selected from the group consisting of oxygen-containing conjugated structures and nitrogen-containing conjugated structures.
13. The method for producing a protein composition according to claim 1, wherein the radical scavenger (RS) has a radical scavenging ability against diphenylpicrylhydrazyl radicals of 0.01 to 90 mg Trolox eq/mg.
14. A protein composition, comprising: a protein (A), wherein the protein composition further contains a radical scavenger (RS), and at least one hydrogen-bond-formable compound (HC) selected from the group consisting of amino acids, peptides, and proteins other than the protein (A), the protein (A) contains at least one functional group selected from the group consisting of sulfide, amide, hydroxyl, amino, and carboxyl groups, the hydrogen-bond-formable compound (HC) contains at least one functional group selected from the group consisting of sulfide, amide, hydroxyl, amino, and carboxyl groups, the at least one functional group in the protein (A) is capable of binding to the at least one functional group in the hydrogen-bond-formable compound (HC) via a hydrogen bond, a weight ratio of the radical scavenger (RS) to the protein (A) in the protein composition [radical scavenger (RS)/protein (A)] is 0.01 to 1.0, a molar ratio of a total molar number of functional groups in the hydrogen-bond-formable compound (HC) to a total molar number of functional groups in the protein (A) in the protein composition [the total molar number of functional groups in the hydrogen-bond-formable compound (HC)/the total molar number of functional groups in the protein (A)] is 0.01 to 0.50, and the protein composition has been radiosterilized.
Description:
TECHNICAL FIELD
[0001] The present invention relates to a method for producing a protein composition and a protein composition.
BACKGROUND ART
[0002] Proteins for use in medical applications and biochemical applications need to be sterilized before use. Sterilization is achieved by ethylene oxide gas sterilization, filtration sterilization, or radiosterilization. Radiosterilization is advantageous in terms of the absence of toxic residues (ethylene oxide gas) after sterilization as well as cost and validation.
[0003] Radiosterilization of proteins unfortunately causes changes such as degradation and denaturation. Such changes in proteins are induced by reactions of active radicals (hydroxy radicals, oxygen radicals) generated by radiation with the proteins.
[0004] Conventionally, the following methods have been employed in order to suppress changes in proteins induced by active radicals: a method in which proteins are irradiated with radiation under cooling conditions; a method in which water is removed from a radiation irradiation target; and a method in which a radical scavenger against active radicals is added (Patent Literatures 1 and 2).
[0005] Yet, the method in which proteins are irradiated with radiation under cooling conditions is not very effective, and the production cost for cooling is high. In addition, when sterilizing a highly hydrophilic protein or a protein that undergoes denaturation by complete removal of water, it is difficult to remove water from a radiation irradiation target. Further, in the case where a radical scavenger is used to prevent changes in proteins induced by active radicals, the radical scavenger needs to be added in a large amount, which unfortunately impairs physiological and physicochemical functions of the proteins.
CITATION LIST
Patent Literature
[0006] Patent Literature 1: JP-T 2003-527210
[0007] Patent Literature 2: JP-T 2010-514747
SUMMARY OF INVENTION
Technical Problem
[0008] The present invention aims to provide a method for producing a protein composition, the method being capable of suppressing changes such as degradation and denaturation of a protein which occur when a highly hydrophilic protein or a protein that undergoes denaturation by complete removal of water is irradiated with radiation.
Solution to Problem
[0009] As a result of extensive studies, the present inventors arrived at the present invention. Specifically, the present invention is directed to a method for producing a protein composition containing a protein (A), a radical scavenger (RS), and at least one hydrogen-bond-formable compound (HC) selected from the group consisting of amino acids, peptides, and proteins other than the protein (A), the method including a sterilization step of radiosterilizing an unsterilized protein composition, wherein the unsterilized protein composition contains the protein (A), the radical scavenger (RS), and the hydrogen-bond-formable compound (HC), the protein (A) contains at least one functional group selected from the group consisting of sulfide, amide, hydroxyl, amino, and carboxyl groups, the hydrogen-bond-formable compound (HC) contains at least one functional group selected from the group consisting of sulfide, amide, hydroxyl, amino, and carboxyl groups, the at least one functional group in the protein (A) is capable of binding to the at least one functional group in the hydrogen-bond-formable compound (HC) via a hydrogen bond, the unsterilized protein composition has a water content of 0 to 30% by weight based on the weight of the unsterilized protein composition, a weight ratio of the radical scavenger (RS) to the protein (A) in the unsterilized protein composition [radical scavenger (RS)/protein (A)] is 0.01 to 1, and a molar ratio of a total molar number of functional groups in the hydrogen-bond-formable compound (HC) to a total molar number of functional groups in the protein (A) in the unsterilized protein composition [the total molar number of functional groups in the hydrogen-bond-formable compound (HC)/the total molar number of functional groups in the protein (A)] is 0.01 to 0.5.
[0010] The present invention also relates to a protein composition containing a protein (A), wherein the protein composition further contains a radical scavenger (RS), and at least one hydrogen-bond-formable compound (HC) selected from the group consisting of amino acids, peptides, and proteins other than the protein (A), the protein (A) contains at least one functional group selected from the group consisting of sulfide, amide, hydroxyl, amino, and carboxyl groups, the hydrogen-bond-formable compound (HC) contains at least one functional group selected from the group consisting of sulfide, amide, hydroxyl, amino, and carboxyl groups, the at least one functional group in the protein (A) is capable of binding to the at least one functional group in the hydrogen-bond-formable compound (HC) via a hydrogen bond, a weight ratio of the radical scavenger (RS) to the protein (A) in the protein composition [radical scavenger (RS)/protein (A)] is 0.01 to 1.0, a molar ratio of a total molar number of functional groups in the hydrogen-bond-formable compound (HC) to a total molar number of functional groups in the protein (A) in the protein composition [the total molar number of functional groups in the hydrogen-bond-formable compound (HC)/the total molar number of functional groups in the protein (A)] is 0.01 to 0.50, and the protein composition has been radiosterilized.
Advantageous Effects of Invention
[0011] According to the production method of the present invention, the addition amount of the radical scavenger (RS) can be reduced by effective scavenging of radicals generated when a highly hydrophilic protein or a protein that undergoes denaturation by complete removal of water is irradiated with radiation. Thus, physiological and physicochemical functions of the protein before being irradiated with radiation are maintained in a protein composition produced by the production method of the present invention.
DESCRIPTION OF EMBODIMENTS
[0012] In the method for producing a protein composition of the present invention, an unsterilized protein composition to be sterilized contains a protein (A), a radical scavenger (RS), and at least one hydrogen-bond-formable compound (HC) selected from the group consisting of amino acids, peptides, and proteins other than the protein (A).
[0013] The term "unsterilized protein composition" as used in the method for producing a protein composition of the present invention refers to a protein composition containing the protein (A), the radical scavenger (RS), and the hydrogen-bond-formable compound (HC) before being subjected to a sterilization step of the method for producing a protein composition of the present invention.
[0014] Examples of the protein (A) include animal-derived proteins, plant-derived proteins, microorganism-derived proteins, and recombinant proteins.
[0015] Examples of animal-derived proteins include protein formulations, enzymes, antibodies, coagulation factors, and extracellular matrices.
[0016] Examples of plant-derived proteins include enzymes and extracellular matrices.
[0017] Examples of microorganism-derived proteins include enzymes and extracellular matrices.
[0018] Examples of recombinant proteins include protein formulations and vaccines.
[0019] Examples of protein formulations include interferon .alpha., interferon 13, interleukin 1 to 12, growth hormone, erythropoietin, insulin, granulocyte-colony stimulating factor (G-CSF), tissue plasminogen activator (TPA), natriuretic peptide, blood coagulation factor VIII, somatomedin, glucagon, growth hormone releasing factor, serum albumin, and calcitonin.
[0020] Examples of vaccines include hepatitis A vaccine, hepatitis B vaccine, and hepatitis C vaccine.
[0021] Examples of enzymes include hydrolases, isomerases, oxidoreductases, transferases, synthases, and lyases.
[0022] Examples of hydrolases include protease, serine protease, amylase, lipase, cellulase, and glucoamylase.
[0023] Examples of isomerases include glucose isomerase.
[0024] Examples of oxidoreductases include peroxidase.
[0025] Examples of transferases include acyltransferase and sulfotransferase.
[0026] Examples of synthases include fatty acid synthase, phosphate synthase, and citrate synthase.
[0027] Examples of lyases include pectin lyase.
[0028] Examples of antibodies include IgD, IgE, IgG, IgA, and IgM.
[0029] Examples of coagulation factors include fibrinogen, fibrin, prothrombin, thrombin, factor III, factor V, factor VII, factor VIII, factor IX, factor X, factor XII, and factor XIII.
[0030] Examples of extracellular matrices include collagen, fibronectin, laminin, and elastin.
[0031] The protein (A) contains at least one functional group selected from the group consisting of sulfide, amide, hydroxyl, amino, and carboxyl groups.
[0032] Preferred among these are hydroxyl, amide, amino, and carboxyl groups in terms of the hydrogen bond distance between the protein (A) and the hydrogen-bond-formable compound (HC).
[0033] The protein (A) containing at least one functional group selected from the group consisting of sulfide, amide, hydroxyl, amino, and carboxyl groups preferably contains an amino acid having the at least one functional group.
[0034] Examples of amino acids having a sulfide group include methionine and cysteine.
[0035] Examples of amide groups include an amide group formed by a peptide bond between amino acids contained in the protein (A).
[0036] Examples of amino acids having a hydroxyl group include serine, threonine, and tyrosine.
[0037] Examples of amino acids having an amino group include arginine, asparagine, glutamine, histidine, lysine, and tryptophan.
[0038] Examples of amino acids having a carboxyl group include aspartic acid and glutamic acid.
[0039] In terms of stability of the protein (A), the protein (A) is preferably one containing methionine, cysteine, serine, threonine, tyrosine, arginine, asparagine, glutamine, histidine, lysine, tryptophan, aspartic acid, and glutamic acid, more preferably one containing methionine, serine, threonine, tyrosine, arginine, asparagine, glutamine, histidine, lysine, tryptophan, aspartic acid, and glutamic acid.
[0040] In the method for producing a protein composition of the present invention, the protein (A) preferably contains a repetitive sequence (X) in terms of stability of the protein.
[0041] In the method for producing a protein composition of the present invention, the repetitive sequence (X) preferably includes any one amino acid sequence (a1) selected from the group consisting of GAGAGS (1), RGD, YIGSR (2), GVGVP (3), PGVGV (4), VPGVG (5), GVPGV (6), VGVPG (7), GPP, GAP, GAHGPAGPK (8), GAA, VAAGY (9), GAGAGAS (10), LGPLGP (11), GAHGPAGPK (12), GAPGPAGPPGSRGDPGPP (13), GAQGPAGPG (14), GAPGAPGSQGAPGLQ (15), GAPGTPGPQGLPGSP (16), GAAVTGRGDSPASAAGY (17), and GAAPGASIKVAVSAGPSAGY (18). The repetitive sequence (X) may include one or two or more of these amino acid sequences (a1).
[0042] In terms of stability of the protein, preferred among these are GAGAGS (1), GAA, VAAGY (9), and GAGAGAS (10).
[0043] In the method for producing a protein composition of the present invention, in terms of stability of the protein, the repetitive sequence (X) includes preferably 2 to 200, more preferably 15 to 150, particularly preferably 30 to 120 units of GAGAGS (1).
[0044] In the method for producing a protein composition of the present invention, in terms of stability of the protein, the repetitive sequence (X) preferably includes a sequence (Y) consisting of 2 to 200 repeats of an amino acid sequence (a2) that is one of GVGVP (3), PGVGV (4), VPGVG (5), GVPGV (6), VGVPG (7), GPP, GAP, or GAHGPAGPK (8) and/or a sequence (Y1) in which 1 to 100 amino acids in the sequence (Y) are replaced by lysine (K) or arginine (R).
[0045] In terms of stability of the protein, the sequence (Y) is particularly preferably a sequence consisting of 2 to 200 repeats of GVGVP (3), PGVGV (4), VPGVG (5), GVPGV (6), or VGVPG (7).
[0046] In addition, the repetitive sequence (X) may include one or two or more of these sequences (Y) and (Y1).
[0047] In the method for producing a protein composition of the present invention, a ratio of a number of units of GAGAGS (1) to a total number of the amino acid sequences (a2) and amino acid sequences (a2') described below in one molecule of the protein (A) [(the number of units of GAGAGS (1)):(the total number of the amino acid sequences (a2) and (a2'))] is preferably [1:2] to [1:20], more preferably [1:10] to [1:5], in terms of stability of the protein, amino acid sequence (a2'): an amino acid sequence in which one to five amino acids in the amino acid sequence (a2) are replaced by lysine (K) or arginine (R).
[0048] In the method for producing a protein composition of the present invention, in terms of bioactivity of the protein, the repetitive sequence (X) preferably includes a sequence (Y2) consisting of 1 to 50 repeats of an amino acid sequence (a3) that is one of GAAVTGRGDSPASAAGY (17) or GAAPGASIKVAVSAGPSAGY (18).
[0049] In addition, the repetitive sequence (X) may include one or two or more of these sequences (Y2).
[0050] In the method for producing a protein composition of the present invention, the protein (A) may contain amino acids immediately upstream and downstream of the repetitive sequence (X) and between the repetitive sequences (X). In terms of solubility (solubility particularly in water) of the protein (A) and gelation time, the number of amino acids immediately upstream and downstream of the repetitive sequence (X) and between the repetitive sequences (X) is preferably 1 to 100, more preferably 5 to 40, particularly preferably 10 to 35.
[0051] Examples of the amino acids immediately upstream and downstream of the repetitive sequence (X) and between the repetitive sequences (X) include .beta.-galactosidase-derived sequences and purified tags (e.g., 6.times.His tag, V5 tag, Xpress tag, AU1 tag, T7 tag, VSV-G tag, DDDDK tag, S tag, CruzTag 09.TM., CruzTag 22.TM., CruzTag 41.TM., Glu-Glu tag, Ha.11 tag, KT3 tag, maltose binding protein, HQ tag, Myc tag, HA tag, and FLAG tag).
[0052] Some of preferred examples of the protein (A) in the method for producing a protein composition of the present invention are listed below.
[0053] (1) Examples of proteins in which the repetitive sequence (X) consists of GAGAGS (1) and the sequence (Y1) include the followings:
protein (SELP 8K) of a sequence (22) having a molecular mass of about 70 kDa, consisting of 12 units of (GAGAGS).sub.4 (19) consisting of four tandem repeats of GAGAGS (1), 13 units of (GVGVP).sub.4GKGVP(GVGVP).sub.3 (20) (Y1-1) in which one valine (V) residue in a repetitive sequence (Y-1) consisting of eight tandem repeats of GVGVP (3) is replaced by lysine (K), and one unit of (GAGAGS).sub.2 (21) consisting of two tandem repeats of GAGAGS (1), wherein these sequences are chemically bound to each other to form (GVGVP).sub.4GKGVP(GVGVP).sub.3 [(GAGAGS).sub.4 (GVGVP).sub.4GKGVP(GVGVP).sub.3].sub.12 (GAGAG S).sub.2; protein (SELP 0K) of a sequence (23) having a molecular mass of about 77 kDa, consisting of 17 units of (GVGVP).sub.4GKGVP(GVGVP).sub.3 (20) and 17 units of (GAGAGS).sub.2 (21), wherein these sequences are chemically bound to each other to form [(GVGVP).sub.4GKGVP (GVGVP).sub.3 (GAGAGS).sub.2].sub.17; protein (SELP 415K) of a sequence (25) having a molecular mass of about 71 kDa, consisting of 16 units of (GAGAGS).sub.2 (21), and eight units of (GVGVP).sub.4GKGVP(GVGVP).sub.11 (24) in which one valine (V) residue in a repetitive sequence (Y-2) consisting of 16 tandem units of GVGVP (3) is replaced by lysine (K), wherein these sequences are chemically bound to each other to form [(GAGAGS).sub.2(GVGVP).sub.4GKGVP(GVGVP).sub.11(GAGAGS).sub.2].sub.8; and protein (SELP 815K) of a sequence (26) having a molecular mass of about 65 kDa, consisting of six units of (GAGAGS).sub.2 (21), six units of (GVGVP).sub.4GKGVP(GVGVP).sub.11 (24), and six units of (GAGAGS).sub.4 (19), wherein these sequences are chemically bound to each other to form [(GAGAGS).sub.2(GVGVP).sub.4GKGVP(GVGVP).sub.11(GAGAGS).sub.4].sub.6.
[0054] In terms of stability of the protein, the protein (A) is preferably SELP 0K or SELP 8K, more preferably SELP 8K, among the above examples.
[0055] (2) Examples of proteins in which the repetitive sequence (X) consists of GAGAGS (1) and the sequence (Y2) include the followings:
protein (ProNectin F) of a sequence (30) having a molecular mass of about 73 kDa, consisting of one unit of (GAGAGS).sub.6 (27) consisting of six tandem repeats of GAGAGS (1), one unit of GAAVTGRGDSPASAAGY (17), one unit of [(GAGAGS).sub.9(GAAVTGRGDSPASAAGY)].sub.2 (29) consisting of twelve tandem repeats of a sequence which is formed by GAAVTGRGDSPASAAGY (17) and (GAGAGS).sub.9 (28) consisting of nine tandem repeats of GAGAGS (1), and one unit of (GAGAGS).sub.2 (21), wherein these sequences are chemically bound to each other to form (GAGAGS).sub.6(GAAVTGRGDSPASAAGY)[(GAGAGS).sub.9(GAAVTGRGDSPASAAGY)].sub.- 12 (GAGAGS).sub.2; and protein (ProNectin L) of a sequence (32) having a molecular mass of about 76 kDa, consisting of one unit of (GAGAGS).sub.6 (27), one unit of GAAPGASIKVAVSAGPSAGY (18), one unit of [(GAGAGS).sub.9(GAAPGASIKVAVSAGPSAGY)].sub.12 (31) consisting of twelve tandem repeats of a sequence which is formed by (GAGAGS).sub.9(28) and GAAPGASIKVAVSAGPSAGY (18), and one unit of (GAGAGS).sub.2 (21), wherein these sequences are chemically bound to each other to form (GAGAGS).sub.6(GAAPGASIKVAVSAGPSAGY)[(GAGAGS).sub.9(GAAPGASIKVAVSAGPS AGY)].sub.12(GAGAGS).sub.2.
[0056] In terms of stability of the protein (A), the amino acid composition of the protein (A) is preferably such that the number of proline (P) residues accounts for 1 to 50%, the number of serine (S) residues accounts for 1 to 50%, and the number of valine (V) residues accounts for 1 to 50%, based on the total number of amino acids in the protein (A). More preferably, the number of proline (P) residues accounts for 1 to 20%, the number of serine (S) residues accounts for 1 to 20%, and the number of valine (V) residues accounts for 1 to 30%.
[0057] In terms of solubility of the protein (A), the protein (A) content of the protein composition is preferably 50% by weight or less, more preferably 10% by weight or less, based on the weight of the protein composition.
[0058] In the method for producing a protein composition of the present invention, the protein (A) preferably has a molecular mass of 15 to 200 kDa as determined by SDS-polyacrylamide gel electrophoresis.
[0059] The molecular mass of the protein (A) is determined by a method in which test samples are isolated by SDS-polyacrylamide gel electrophoresis and the migration distance of each test sample is compared with that of the standard substance.
[0060] In the method for producing a protein composition of the present invention, in terms of stability of the protein (A), the radical scavenger (RS) in the protein composition is preferably at least one selected from the group consisting of oxygen-containing conjugated structures and nitrogen-containing conjugated structures.
[0061] In the method for producing a protein composition of the present invention, the radical scavenger (RS) preferably has a radical scavenging ability against diphenylpicrylhydrazyl radicals (DPPH radicals) of 0.01 to 90 mg Trolox eq/mg.
[0062] The DPPH radical scavenging ability can be measured by the method described in "Shokuhin kinosei hyoka manyuarushu dainishu (the second collection of food functionality evaluation manuals)", DPPH radical scavenging activity evaluation method, Tomoyuki Oki, (2008) pp. 71-78, and can be evaluated as trolox equivalent.
[0063] In addition, the radical scavenging ability against peroxy radicals, hydroxy radicals, 2,2'-azino-bis-(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) radicals, oxygen radicals, and alkyl radicals can be measured by a method such as superoxide dismutase assay (SOD assay), ABTS radical scavenging ability measurement method, potential antioxidant (PAO) measurement method, or EPR spin trapping method to set the radical scavenging ability to 0.01 mg Trolox eq/mg or more.
[0064] Examples of the radical scavenger (RS) include organic acids (e.g., ascorbic acid, erythorbic acid, uric acid, gallic acid, glutathione, phenolic acid, ellagic acid, and chlorogenic acid), glutathione, edaravone, polyphenols (e.g., flavonoid, phenolic acid, ellagic acid, lignan, curcumin, and coumarin), and phenolic compounds (e.g., vanillin, pyrogallol, dibutylhydroxytoluene, and butylhydroxyanisole).
[0065] In particular, in terms of miscibility between the protein (A) and the radical scavenger (RS), radical scavenging ability, and safety, the radical scavenger (RS) is preferably ascorbic acid, edaravone, vanillin, gallic acid, glutathione, or chlorogenic acid, more preferably ascorbic acid or edaravone.
[0066] In terms of solubility, the radical scavenger (RS) content of the unsterilized protein composition is preferably 40% by weight or less, more preferably 30% by weight or less, based on the weight of the unsterilized protein composition.
[0067] In the method for producing a protein composition of the present invention, the hydrogen-bond-formable compound (HC) contains at least one functional group selected from the group consisting of sulfide, amide, hydroxyl, amino, and carboxyl groups.
[0068] In terms of the hydrogen bond distance between the protein (A) and the hydrogen-bond-formable compound (HC), the hydrogen-bond-formable compound (HC) preferably contains at least one functional group selected from the group consisting of carboxyl, hydroxyl, and amino groups, among the above examples.
[0069] Examples of the hydrogen-bond-formable compound (HC) include amino acids (e.g., alanine, arginine, asparagine, aspartic acid, cysteine, glutamine, glutamic acid, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine, and their derivatives) and peptides (e.g., aspartame, vasopressin, glucagon, and selectin).
[0070] In terms of the hydrogen bond distance and miscibility between the protein (A) and the hydrogen-bond-formable compound (HC), the hydrogen-bond-formable compound (HC) is preferably tryptophan, tyrosine, or histidine, more preferably tryptophan, among the above examples.
[0071] In terms of solubility, the hydrogen-bond-formable compound (HC) content of the unsterilized protein composition is preferably 25% by weight or less, more preferably 10% by weight or less, based on the weight of the unsterilized protein composition.
[0072] In the method for producing a protein composition of the present invention, the water content of the unsterilized protein composition is 0 to 30% by weight based on the weight of the unsterilized protein composition. In terms of stability of the protein, the water content is preferably 0.01 to 30% by weight, more preferably 0.01 to 15% by weight.
[0073] In the method for producing a protein composition of the present invention, the unsterilized protein composition may be dried before the sterilization step.
[0074] Examples of the method of drying the unsterilized protein composition include freeze-drying and heat-drying.
[0075] The water content of the unsterilized protein composition can be measured as described below.
<Method for Measuring the Water Content of the Unsterilized Protein Composition>
[0076] An amount of 50 to 100 mg of the unsterilized protein composition is weighed in a glass vial. The weighed amount (Ws0), and the weight of the glass vial (Wb0) are recorded. A dryer is set to 100.degree. C., and the glass vial containing the unsterilized protein composition is placed in the dryer when the temperature reaches 100.degree. C. (The glass vial is uncapped.) Two hours later, the glass vial containing the unsterilized protein composition is taken out from the dryer, and is left to cool to room temperature in a desiccator. After cooling, the glass vial is capped, and the weight (W) is measured. Then, the water content of the unsterilized protein composition is calculated from the following formula (1).
(Ws0+Wb0-W)/Ws0.times.100=Water content (% by weight) of the unsterilized protein composition) (1)
[0077] In the method for producing a protein composition of the present invention, a weight ratio of the radical scavenger (RS) to the protein (A) in the unsterilized protein composition [radical scavenger (RS)/protein (A)] is 0.01 to 1.0. In terms of maintenance of physiological and physicochemical functions of the protein (A), the weight ratio is preferably 0.01 to 0.1, more preferably 0.01 to 0.05.
[0078] In the method for producing a protein composition of the present invention, a molar ratio of a total molar number of functional groups in the hydrogen-bond-formable compound (HC) to a total molar number of functional groups in the protein (A) in the unsterilized protein composition [the total molar number of functional groups in the hydrogen-bond-formable compound (HC)/the total molar number of functional groups in the protein (A)] is 0.01 to 0.50. In terms of protection of protein properties, the molar ratio is preferably 0.01 to 0.50, more preferably 0.01 to 0.10, still more preferably 0.01 to 0.05.
[0079] If the molar ratio exceeds 1.0, disadvantages resulting from the radical scavenger (RS) (e.g., changes in physiological and physicochemical functions, changes in pH environment, increased costs, inflammation, and carcinogenesis) will increase.
[0080] If the molar ratio is less than 0.01, the protein (A) will be denatured to a greater degree.
[0081] The "functional groups in the protein (A)" used for the calculation of the molar ratio refers to the functional groups in the protein (A) which form hydrogen bonds with the functional groups in the hydrogen-bond-formable compound (HC). The "functional groups in the hydrogen-bond-formable compound (HC)" used for the calculation of the molar ratio refers to the functional groups in the hydrogen-bond-formable compound (HC) which forms hydrogen bonds with the functional groups in the protein (A).
[0082] In the method for producing a protein composition of the present invention, as described above, the protein (A) contains at least one functional group selected from the group consisting of sulfide, amide, hydroxyl, amino, and carboxyl groups.
[0083] In addition, in the method for producing a protein composition of the present invention, the at least one functional group in the protein (A) is capable of binding to the at least one functional group in the hydrogen-bond-formable compound (HC) via a hydrogen bond.
[0084] It is particularly preferred that the functional groups in the hydrogen-bond-formable compound (HC) can form hydrogen bonds with the functional groups in the amino acids in the protein (A) that is easily denatured when irradiated with radiation. The presence of the hydrogen-bond-formable compound (HC) in the unsterilized protein composition facilitates prevention of denaturation of the protein (A) in the sterilization step.
[0085] Examples of the amino acids in the protein (A) that is easily denatured when irradiated with radiation include serine and aspartic acid.
[0086] The functional groups of the protein (A) may be on side chains of the amino acids in the protein (A).
[0087] In the case where these functional groups are on the side chains of the amino acids, the functional groups on the side chains of the amino acids in the protein (A) are capable of binding to the functional groups of the hydrogen-bond-formable compound (HC) via first hydrogen bonds. In terms of radical scavenging properties, each first hydrogen bond has a distance of preferably 1.3 to 1.9 A, more preferably 1.7 to 1.8 .ANG..
[0088] In addition, an amide group, which is one of the functional groups in the protein (A) and which is formed by a peptide bond, is also in the protein (A).
[0089] The amide group formed by a peptide bond in the protein (A) is capable of binding to the hydrogen-bond-formable compound (HC) via a second hydrogen bond. In terms of radical scavenging properties, the second hydrogen bond has a distance of preferably 1.3 to 1.9 .ANG., more preferably 1.7 to 1.8 .ANG..
[0090] The hydrogen bond distance is calculated using simulation software (Gaussian: Gaussian, Inc.).
[0091] When calculating the hydrogen bond distance by simulation software (Gaussian), an amino acid having a predetermined functional group is selected as a model compound for the compound having the predetermined functional group in the protein (A). Then, the hydrogen bond distance between the functional group in the amino acid and the functional group in the hydrogen-bond-formable compound (HC) can be determined by calculation.
[0092] The hydrogen bond distance between the functional group in the amino acid and the functional group in the hydrogen-bond-formable compound (HC) refers to the hydrogen bond distance that is optimized such that the energy between these functional groups is minimized.
[0093] In the method for producing a protein composition of the present invention, in the case where the first hydrogen bond has a distance of 1.3 to 1.9 .ANG. and the second hydrogen bond has a distance of 1.3 to 1.9 .ANG., these distances are shorter than the typical hydrogen bond distance (2.4 to 3.3 .ANG.).
[0094] Thus, the presence of the hydrogen-bond-formable compound (HC) in the unsterilized protein composition can suppress denaturation of the protein (A) by radiation in the sterilization step. This is presumably because the hydrogen-bond-formable compound (HC) fulfills the role of facilitating transfer of radicals from the protein (A) to the radical scavenger (RS) through hydrogen bonds. Due to this synergistic effect, it is possible to drastically reduce the addition amount of the radical scavenger (RS) (the amount is reduced to about one hundredth), compared to the case where an attempt is made to suppress denaturation only by the radical scavenger (RS). This reduces disadvantages (e.g., changes in physiological and physicochemical functions, changes in pH environment, increased costs, inflammation induced by a protein to be produced, and carcinogenic properties of a protein to be produced) resulting from the addition of a large amount of the radical scavenger (RS) to the unsterilized protein composition.
[0095] In addition, in the method for producing a protein composition of the present invention, the hydrogen-bond-formable compound (HC) preferably binds to the protein (A) only via hydrogen bonds.
[0096] In the case where a compound that forms a covalent bond with the protein (A) is used instead of the hydrogen-bond-formable compound (HC), such a compound can also exhibit an equivalent function (role of facilitating transfer radicals from the protein (A) to the radical scavenger (RS)) to that of the hydrogen-bond-formable compound (HC); however, formation of such a covalent bond unfortunately changes physical and physiological functions of the protein (A). In contrast, in the case where the hydrogen-bond-formable compound (HC) binds to the protein (A) only via hydrogen bonds without forming covalent bonds, the above described disadvantages (e.g., changes in physiological and physicochemical functions and changes in safety) are prevented.
[0097] As a method for adjusting the hydrogen bond distance between at least one functional group selected from the group consisting of sulfide, amide, hydroxyl, amino, and carboxyl groups in the protein (A) and the functional group in the hydrogen-bond-formable compound (HC), for example, various functional groups, proteins, and hydrogen-bond-formable compounds (HC) are selected such that the hydrogen bond distance between at least one functional group selected from the group consisting of hydroxyl, amino, and carboxyl groups in the protein (A) and the functional group in the hydrogen-bond-formable compound (HC) is within the numerical range of 1.3 to 1.9 .ANG..
[0098] In other words, in the method for producing a protein composition of the present invention, the hydrogen-bond-formable compounds (HC) are preferably selected according to the type and other properties of the protein (A).
[0099] The hydrogen-bond-formable compounds (HC) may be screened by a method such as screening (1) or screening (2) described below.
<Screening (1)>
[0100] First, the protein (A) is irradiated with radiation to sterilize the protein (A). Subsequently, an amino acid (a) modified in the protein (A) irradiated with radiation is identified. Subsequently, the hydrogen-bond-formable compounds (HC) may be screened with the above-described simulation software or the like, using the amino acid (a) before modification as a model compound for the compound having a functional group on a side chain of an amino acid in the protein (A).
[0101] The modified amino acid (a) can be identified by LC-MSMS analysis. The LC-MSMS analysis conditions are preferably the same as those for "LC-MSMS measurement" (described later) for the calculation of the modification rate of the protein (A) using LC-MSMS.
[0102] The compounds (HC) capable of forming the first hydrogen bond can be screened by the method described here.
<Screening (2)>
[0103] The hydrogen-bond-formable compounds (HC) may be screened with the above-described simulation software or the like, using alanylalanine as a model compound for the compound having an amide group formed by a peptide bond in the protein (A).
[0104] The compounds (HC) capable of forming the second hydrogen bond can be screened by the method described here.
[0105] In the method for producing a protein composition of the present invention, the unsterilized protein composition may contain optional additives, in addition to the protein (A), the radical scavenger (RS), and the hydrogen-bond-formable compound (HC).
[0106] Examples of optional additives include antioxidants, antiseptics, stabilizers, solubilizing agents, and buffer components.
[0107] The method for producing a protein composition of the present invention includes the sterilization step of radiosterilizing the unsterilized protein composition.
[0108] The method for producing a protein composition of the present invention may also include, before the sterilization step, an unsterilized protein composition preparation step of preparing an unsterilized protein composition, a freeze-drying step of freeze-drying the unsterilized protein composition, and a packing step of packing the unsterilized protein composition, as described below.
(Unsterilized Protein Composition Preparation Step)
[0109] Examples of methods for preparing the unsterilized protein composition include a method in which the hydrogen-bond-formable compound (HC), the radical scavenger (RS), and the protein (A) are dissolved in water at room temperature. Any sterile water may be used. Examples of methods for sterilizing water include a method for filtering water through a microfiltration membrane having a pore diameter of 0.2 .mu.m or less, a method for filtering water through an ultrafiltration membrane, a method for filtering water through a reverse osmosis membrane, and a method for heat-sterilizing water in an autoclave at 121.degree. C. for 20 minutes to obtain ion-exchanged water.
(Freeze-Drying Step)
[0110] Examples of methods for freeze-drying the unsterilized protein composition include a method in which the temperature is lowered to about -30.degree. C. to -35.degree. C. to freeze the unsterilized protein composition. Then, the pressure is reduced to a vacuum state and the temperature is raised to about -10.degree. C. to -20.degree. C. (a temperature at which the equilibrium water vapor pressure is equal to or higher than the degree of vacuum) to sublime water.
[0111] Facility conditions are listed below, as an example.
Facility: freeze dryer "FD-10BM" (Nihon Techno Service, Co., Ltd.) Freezing conditions: -30.degree. C. (15 h) Primary drying conditions: -10.degree. C. (72 h) Secondary drying conditions: 10.degree. C. (72 h) Degree of vacuum: 1 Pa to 10 Pa
(Packing Step)
[0112] In the method for producing a protein composition of the present invention, before the sterilization step, the unsterilized protein composition may be packed to be shielded from the outside.
[0113] Examples of methods for packing include a vacuum packing method.
(Sterilization Step)
[0114] In the method for producing a protein composition of the present invention, examples of methods for radiosterilizing the unsterilized protein composition in the sterilization step include methods such as .gamma.-ray sterilization and electron beam sterilization under the following conditions.
Irradiation facility: SHI-ATEX Co., Ltd. Irradiation dose: 25 to 27 kGy Environmental temperature during irradiation: -10.degree. C. to 10.degree. C.
[0115] In addition, in the method for producing a protein composition of the present invention, the protein composition is preferably sterilized to SAL 10.sup.-6 in accordance with JIS T 0806-2:2010 or ISO 11137-2:2006 in the sterilization step.
[0116] In addition, in the method for producing a protein composition of the present invention, the sterilization step may be performed only once or several times.
[0117] According to the method for producing a protein composition of the present invention, it is possible to produce a protein composition having a low denaturation rate. In particular, "the denaturation rate calculated based on HPLC measurement" and "the denaturation rate of the produced protein composition calculated based on LC-MSMS measurement", which are measured by the following methods, can be reduced.
[0118] As used herein, the term "denaturation rate of the produced protein composition calculated based on HPLC measurement" refers to a numerical value calculated from the following formula (2), wherein M is the peak height of the unsterilized protein composition and N is the peak height of the produced protein composition, as determined by HPLC measurement of the unsterilized protein composition and the produced protein composition under the conditions described below.
Denaturation rate (%)=[1-(N/M)].times.100 (2)
(HPLC Measurement)
[0119] The unsterilized protein composition or the produced protein composition is dissolved in deionized water (1 mL) to obtain a solution containing 1 mg of the protein (A), and the solution is filtered through a 0.45-.mu.m filter to obtain a test sample.
[0120] The test sample is measured by HPLC (Shimadzu Corporation) under the following conditions.
Column: Jupiter C4
Mobile Phase:
[0121] A: 99.85% by weight of water+0.15% by weight of trichloroacetic acid
[0122] B: 34% by weight of acetonitrile+65.85% by weight of water+0.15% by weight of trichloroacetic acid
[0123] C: 80% by weight of acetonitrile+19.85% by weight of water+0.15% by weight of trichloroacetic acid
Flow rate: 1 mL/min Mode: curved gradient mode (A/B=86/14 to A/B=20/80 to C=100) Measurement wavelength: 214 nm
[0124] Generally, proteins in a protein composition become hydrophilic when the protein composition is radiosterilized. Thus, the peak in HPLC analysis of the radiosterilized protein composition is broad and low. Conversely, if the percentage of denatured proteins is low, the peak in HPLC analysis is sharp and is not likely to be low.
[0125] As used herein, the term "denaturation rate of the produced protein composition calculated based on LC-MSMS measurement" refers to a numerical value calculated from the following formula (3), wherein O.sub.n is the concentration of each amino acid in the unsterilized protein composition, P.sub.n is the concentration of each amino acid in the produced protein composition, and Q is the number of types of amino acids measured, as determined by LC-MSMS measurement of the unsterilized protein composition and the produced protein composition under the conditions described below.
Denaturation rate (%)=1/Q.times..SIGMA.[1-(P.sub.n/O.sub.n)].times.100 (3)
(LC-MSMS Measurement)
[0126] The unsterilized protein composition or the produced protein composition is added to 6N hydrochloric acid (200 .mu.L) to obtain a solution containing 1 mg of the protein (A), followed by degassing. The solution is degassed until foam is no longer formed, and then the protein (A) in the solution is hydrolyzed under vacuum sealed conditions at 110.degree. C. for 22 hours. After hydrolysis, the solution is diluted in deionized water to 800 .mu.L. The diluted solution is filtered through a 0.45-.mu.m filter to obtain a test sample.
[0127] The test sample is measured by LC-MSMS (Shimadzu Corporation) under the following conditions.
Column: InertSustain C18 (GL Sciences Inc.)
Mobile Phase:
[0128] A: 0.05 M aqueous solution of trifluoroacetic acid
[0129] B: Methanol
[0130] A/B=95/5 (V/V)
Flow rate: 0.2 mL/min Ion source: ESI (+) Measurement mode: MRM (MSMS)
[0131] The amino acid composition is determined from the elution time and the molecular weight of the standard sample (standard amino acid mixture: type H).
[0132] The method for producing a protein composition of the present invention is a method for producing a protein composition for use in medical applications and biochemical applications. The method is used to prevent radiosterilization-induced changes in proteins such as degradation and denaturation.
[0133] A protein composition produced by the method for producing a protein composition of the present invention is also encompassed by the present invention.
[0134] Specifically, the present invention is directed to a protein composition containing a protein (A), wherein the protein composition further contains a radical scavenger (RS), and at least one hydrogen-bond-formable compound (HC) selected from the group consisting of amino acids, peptides, and proteins other than the protein (A), the protein (A) contains at least one functional group selected from the group consisting of sulfide, amide, hydroxyl, amino, and carboxyl groups, the hydrogen-bond-formable compound (HC) contains at least one functional group selected from the group consisting of sulfide, amide, hydroxyl, amino, and carboxyl groups, the at least one functional group in the protein (A) is capable of binding to the at least one functional group in the hydrogen-bond-formable compound (HC) via a hydrogen bond, a weight ratio of the radical scavenger (RS) to the protein (A) in the protein composition [radical scavenger (RS)/protein (A)] is 0.01 to 1.0, a molar ratio of a total molar number of functional groups in the hydrogen-bond-formable compound (HC) to a total molar number of functional groups in the protein (A) in the protein composition [the total molar number of functional groups in the hydrogen-bond-formable compound (HC)/the total molar number of functional groups in the protein (A)] is 0.01 to 0.50, and the protein composition has been radiosterilized.
[0135] In the protein composition of the present invention, the weight ratio of the radical scavenger (RS) to the protein (A) in the protein composition [radical scavenger (RS)/protein (A)] is 0.01 to 1.0, preferably 0.01 to 0.1, more preferably 0.01 to 0.05.
[0136] As described above, the production of the protein composition of the present invention involves radiosterilization. When the weight ratio of the radical scavenger (RS) to the protein (A) in the protein composition [radical scavenger (RS)/protein (A)] is 0.01 to 1.0, radiosterilization is less likely to produce a denatured form of the protein (A), which facilitates maintenance of physiological and physicochemical functions of the protein (A).
[0137] In the protein composition of the present invention, the molar ratio of the total molar number of functional groups in the hydrogen-bond-formable compound (HC) to the total molar number of functional groups in the protein (A) in the protein composition [the total molar number of functional groups in the hydrogen-bond-formable compound (HC)/the total molar number of functional groups in the protein (A)] is 0.01 to 0.50, preferably 0.01 to 0.10, more preferably 0.01 to 0.05.
[0138] As described above, the production of the protein composition of the present invention involves radiosterilization.
[0139] When the molar ratio of the total molar number of functional groups in the hydrogen-bond-formable compound (HC) to the total molar number of functional groups in the protein (A) in the protein composition [the total molar number of functional groups in the hydrogen-bond-formable compound (HC)/the total molar number of functional groups in the protein (A)] is 0.01 to 0.50, disadvantages resulting from the radical scavenger (RS) (e.g., changes in physiological and physicochemical functions, changes in pH environment, increased costs, inflammation, and carcinogenesis) are reduced. In addition, when radiosterilization is performed, the protein (A) is less likely to be denatured. Therefore, physiological and physicochemical functions of the protein (A) can be maintained.
[0140] The protein composition of the present invention has been radiosterilized.
[0141] Thus, use of the protein composition of the present invention in medical applications and biochemical applications can suitably prevent contamination.
[0142] The protein composition of the present invention has been preferably radiosterilized at 25 to 27 kGy.
[0143] The protein composition of the present invention has been more preferably sterilized to SAL 10.sup.-6 in accordance with JIS T 0806-2:2010 or ISO 11137-2:2006. The protein composition of the present invention that has been sterilized as described above is also usable as a medicinal product.
[0144] In the protein composition of the present invention, the protein composition preferably has a water content of 0 to 30% by weight, more preferably 0.01 to 30% by weight, still more preferably 0.01 to 15% by weight, based on the weight of the protein composition.
[0145] When the water content of the protein composition is 0 to 30% by weight based on the weight of the protein composition, the protein (A) in the protein composition has higher stability.
[0146] The protein composition of the present invention is preferably packed, more preferably vacuum-packed.
[0147] The protein composition when packed is shielded from the outside, and is thus less susceptible to contamination.
EXAMPLES
[0148] The present invention is described in more detail below with reference to examples and comparative examples, but the present invention is not limited thereto.
(Provision of Radical Scavenger (RS))
[0149] Various radical scavengers (RS) shown in Table 1 were provided. Table 1 shows the radical scavenging ability and the structure of each radical scavenger.
TABLE-US-00001 TABLE 1 Radical scavenging ability Radical scavenger (RS) (mg Trolox eq/mg) Structure of radical scavenger (RS) Ascorbic acid 48.00 Oxygen-containing conjugated structure Edaravone 63.00 Oxygen-containing conjugated structure Nitrogen-containing conjugated structure Vanillin 0.05 Oxygen-containing conjugated structure Catechin 28.00 Oxygen-containing conjugated structure Gallic acid 86.00 Oxygen-containing conjugated structure Glutathione 0.15 Nitrogen-containing conjugated structure Oxygen-containing conjugated structure Chlorogenic acid 0.76 Oxygen-containing conjugated structure
(Screening of Hydrogen-Bond-Formable Compounds (HC))
[0150] First, as the protein (A), each of SELP 8K (sequence (22)), ProNectin F (sequence (30)), ProNectin L (sequence (32)), HRP-conjugated rabbit antibody (sequence (33)), glucose oxidase (sequence (34)), and bovine serum albumin (sequence (35)) was dissolved in water and, and these aqueous solutions were each freeze-dried, followed by vacuum-packing in a nitrogen atmosphere. Each vacuum-packed protein (A) was irradiated with electron beam at 25 kGy at -20.degree. C.
[0151] Subsequently, the amino acid composition of the protein (A) before electron beam irradiation and the amino acid composition of the protein (A) after electron beam irradiation were measured by the following method to identify an amino acid modified by the electron beam irradiation.
<Evaluation: Amino Acid Analysis>
[0152] Each protein (1 mg) was individually added to 6N hydrochloric acid (200 .mu.L), followed by degassing. The solution was degassed until foam was no longer formed, and then the protein (A) in the solution was hydrolyzed under vacuum sealed conditions at 110.degree. C. for 22 hours. After hydrolysis, the solution was diluted in deionized water to 800 .mu.L. The diluted solution was filtered through a 0.45-.mu.m filter to obtain a test sample. Table 3 shows the results.
[0153] Analysis was performed by LC-MSMS (Shimadzu Corporation) under the following conditions.
Column: InertSustain C18 (GL Sciences Inc.)
Mobile Phase:
[0154] A: 0.05 M aqueous solution of trifluoroacetic acid
[0155] B: methanol
[0156] A/B=95/5 (V/V)
Flow rate: 0.2 mL/min Ion source: ESI (+) Measurement mode: MRM (MSMS)
[0157] The amino acid composition was determined from the elution time and the molecular weight of the standard sample (standard amino acid mixture: type H).
[0158] The amino acid in the protein (A) modified by the electron beam irradiation was serine.
[0159] Next, the compounds (HC) capable of forming a hydrogen bond with a hydroxyl group on the side chain of serine were screened with simulation software (Gaussian).
[0160] In addition, the compounds (HC) capable of forming a hydrogen bond with an amide group in the peptide bond of alanylalanine were screened.
[0161] As a result of screening, tryptophan, tyrosine, and histidine were identified as the hydrogen-bond-formable compounds (HC).
[0162] A hydroxyl group on the side chain of serine is considered to form a hydrogen bond (first hydrogen bond) with a carboxyl group on the side chain of tryptophan, a hydroxyl group on the side chain of tyrosine, or a carboxyl group on the side chain of histidine. Table 2 shows the distance (.ANG.) of each first hydrogen bond.
[0163] An amide group in the peptide bond of alanylalanine is considered to form a hydrogen bond (second hydrogen bond) with a carboxyl group on the side chain of tryptophan, a hydroxyl group on the side chain of tyrosine, or a carboxyl group on the side chain of histidine. Table 2 shows the distance (.ANG.) of each second hydrogen bond.
TABLE-US-00002 TABLE 2 Hydrogen bond distance (.ANG.) Hydrogen-bond-formable Model compound compound (HC) Serine Alanyl alanine Tryptophan 1.778 1.774 Tyrosine 1.812 1.776 Histidine 1.802 1.823
Examples 1 to 32
[0164] Radiosterilization of Protein Compositions Each Containing SELP 8K
[0165] SELP 8K as the protein (A), the hydrogen-bond-formable compound (HC), the radical scavenger (RS), and water were mixed according to the weight ratio and the molar ratio described in Table 3 to obtain an aqueous solution of an unsterilized protein composition containing 2.4% by weight of SELP 8K for each example.
[0166] Subsequently, these unsterilized protein composition were freeze-dried and vacuum-packed in a nitrogen atmosphere. Each unsterilized protein had a water content of 8% by weight. The vacuum-packed unsterilized protein compositions were irradiated with electron beam at 25 kGy at -20.degree. C. to produce protein compositions according to Examples 1 to 32.
Examples 33 to 65
[0167] Radiosterilization of Protein Compositions Each Containing ProNectin F
[0168] ProNectin F as the protein (A), the hydrogen-bond-formable compound (HC), the radical scavenger (RS), and water were mixed according to the weight ratio and the molar ratio described in Table 4 to obtain an aqueous solution of an unsterilized protein composition containing 2.4% by weight of ProNectin F for each example.
[0169] Subsequently, these unsterilized protein composition were freeze-dried and vacuum-packed in a nitrogen atmosphere. Each unsterilized protein had a water content of 5% by weight. The vacuum-packed unsterilized protein compositions were irradiated with electron beam at 25 kGy at -20.degree. C. to produce protein compositions according to Examples 33 to 65.
Examples 66 to 97
[0170] Radiosterilization of Protein Compositions Each Containing ProNectin L
[0171] ProNectin L as the protein (A), the hydrogen-bond-formable compound (HC), the radical scavenger (RS), and water were mixed according to the weight ratio and the molar ratio described in Table 5 to obtain an aqueous solution of an unsterilized protein composition containing 2.4% by weight of ProNectin L for each example.
[0172] Subsequently, these unsterilized protein composition were freeze-dried and vacuum-packed in a nitrogen atmosphere. Each unsterilized protein had a water content of 4% by weight. The vacuum-packed unsterilized protein compositions were irradiated with electron beam at 25 kGy at -20.degree. C. to produce protein compositions according to Examples 66 to 97.
Example 98
[0173] Radiosterilization of a Protein Composition Containing HRP-Conjugated Rabbit Antibody
[0174] HRP-conjugated rabbit antibody as the protein (A), the hydrogen-bond-formable compound (HC), the radical scavenger (RS), and water were mixed according to the weight ratio and the molar ratio described in Table 6 to obtain an aqueous solution of an unsterilized protein composition containing 0.1% by weight of HRP-conjugated rabbit antibody.
[0175] Subsequently, the unsterilized protein composition was freeze-dried and vacuum-packed in a nitrogen atmosphere. The unsterilized protein had a water content of 7% by weight. The vacuum-packed unsterilized protein composition was irradiated with electron beam at 25 kGy at -20.degree. C. to produce a protein composition according to Example 98.
Example 99
[0176] Radiosterilization of a Protein Composition Containing Glucose Oxidase
[0177] Glucose oxidase as the protein (A), the hydrogen-bond-formable compound (HC), the radical scavenger (RS), and water were mixed according to the weight ratio and the molar ratio described in Table 6 to obtain an aqueous solution of an unsterilized protein composition containing 2.4% by weight of glucose oxidase.
[0178] Subsequently, the unsterilized protein composition was freeze-dried and vacuum-packed in a nitrogen atmosphere. The unsterilized protein had a water content of 6% by weight. The vacuum-packed unsterilized protein composition was irradiated with electron beam at 25 kGy at -20.degree. C. to produce a protein composition according to Example 99.
Example 100
[0179] Radiosterilization of a Protein Composition Containing Bovine Serum Albumin
[0180] Bovine serum albumin as the protein (A), the hydrogen-bond-formable compound (HC), the radical scavenger (RS), and water were mixed according to the weight ratio and the molar ratio described in Table 6 to obtain an aqueous solution of an unsterilized protein composition containing 2.4% by weight of bovine serum albumin.
[0181] Subsequently, the unsterilized protein composition was freeze-dried and vacuum-packed in a nitrogen atmosphere. The unsterilized protein had a water content of 5% by weight. The vacuum-packed unsterilized protein composition was irradiated with electron beam at 25 kGy at -20.degree. C. to produce a protein composition according to Example 100.
Comparative Example 1
[0182] Radiosterilization of a Protein Composition Containing SELP 8K
[0183] SELP 8K as the protein (A) and water were mixed to obtain an aqueous solution of an unsterilized protein composition containing 2.4% by weight of SELP 8K.
[0184] Subsequently, the unsterilized protein composition was freeze-dried and vacuum-packed in a nitrogen atmosphere. The unsterilized protein had a water content of 8% by weight. The vacuum-packed unsterilized protein composition was irradiated with electron beam at 25 kGy at -20.degree. C. to produce a protein composition according to Comparative Example 1.
Comparative Example 2
[0185] Radiosterilization of a Protein Composition Containing ProNectin F
[0186] ProNectin F as the protein (A) and water were mixed to obtain an aqueous solution of an unsterilized protein composition containing 2.4% by weight of ProNectin F.
[0187] Subsequently, the unsterilized protein composition was freeze-dried and vacuum-packed in a nitrogen atmosphere. The unsterilized protein had a water content of 5% by weight. The vacuum-packed unsterilized protein composition was irradiated with electron beam at 25 kGy at -20.degree. C. to produce a protein composition according to Comparative Example 2.
Comparative Example 3
[0188] Radiosterilization of a Protein Composition Containing ProNectin L
[0189] ProNectin L as the protein (A) and water were mixed to obtain an aqueous solution of an unsterilized protein composition containing 2.4% by weight of ProNectin L.
[0190] Subsequently, the unsterilized protein composition was freeze-dried and vacuum-packed in a nitrogen atmosphere. The unsterilized protein had a water content of 4% by weight. The vacuum-packed unsterilized protein composition was irradiated with electron beam at 25 kGy at -20.degree. C. to produce a protein composition according to Comparative Example 3.
Comparative Example 4
[0191] Radiosterilization of a Protein Composition Containing HRP-Conjugated Rabbit Antibody
[0192] HRP-conjugated rabbit antibody as the protein (A) and water were mixed to obtain an aqueous solution of an unsterilized protein composition containing 0.1% by weight of HRP-conjugated rabbit antibody.
[0193] Subsequently, the unsterilized protein composition was freeze-dried and vacuum-packed in a nitrogen atmosphere. The unsterilized protein had a water content of 7% by weight. The vacuum-packed unsterilized protein composition was irradiated with electron beam at 25 kGy at -20.degree. C. to produce a protein composition according to Comparative Example 4.
Comparative Example 5
[0194] Radiosterilization of a Protein Composition Containing Glucose Oxidase
[0195] Glucose oxidase as the protein (A) and water were mixed to obtain an aqueous solution of an unsterilized protein composition containing 2.4% by weight of glucose oxidase.
[0196] Subsequently, the unsterilized protein composition was freeze-dried and vacuum-packed in a nitrogen atmosphere. The unsterilized protein had a water content of 6% by weight. The vacuum-packed unsterilized protein composition was irradiated with electron beam at 25 kGy at -20.degree. C. to produce a protein composition according to Comparative Example 5.
Comparative Example 6
[0197] Radiosterilization of a Protein Composition Containing Bovine Serum Albumin
[0198] Bovine serum albumin as the protein (A) and water were mixed to obtain an aqueous solution of an unsterilized protein composition containing 2.4% by weight of bovine serum albumin.
[0199] Subsequently, the unsterilized protein composition was freeze-dried and vacuum-packed in a nitrogen atmosphere. The unsterilized protein had a water content of 5% by weight. The vacuum-packed unsterilized protein composition was irradiated with electron beam at 25 kGy at -20.degree. C. to produce a protein composition according to Comparative Example 6.
Comparative Example 7
[0200] Radiosterilization of a Protein Composition Containing SELP 8K
[0201] A protein composition according to Comparative Example 7 was produced as in Comparative Example 1, except that ascorbic acid as the radical scavenger was added in the proportion shown in Table 7.
Comparative Example 8
[0202] Radiosterilization of a Protein Composition Containing ProNectin F
[0203] A protein composition according to Comparative Example 8 was produced as in Comparative Example 2, except that ascorbic acid as the radical scavenger was added in the proportion shown in Table 7.
Comparative Example 9
[0204] Radiosterilization of a Protein Composition Containing ProNectin L
[0205] A protein composition according to Comparative Example 9 was produced as in Comparative Example 3, except that ascorbic acid as the radical scavenger was added in the proportion shown in Table 7.
Comparative Example 10
[0206] Radiosterilization of a Protein Composition Containing HRP-Conjugated Rabbit Antibody
[0207] A protein composition according to Comparative Example 10 was produced as in Comparative Example 4, except that ascorbic acid as the radical scavenger was added in the proportion shown in Table 7.
Comparative Example 11
[0208] Radiosterilization of a Protein Composition Containing Glucose Oxidase
[0209] A protein composition according to Comparative Example 11 was produced as in Comparative Example 5, except that ascorbic acid as the radical scavenger was added in the proportion shown in Table 7.
Comparative Example 12
[0210] Radiosterilization of a Protein Composition Containing Bovine Serum Albumin
[0211] A protein composition according to Comparative Example 12 was produced as in Comparative Example 6, except that ascorbic acid as the radical scavenger was added in the proportion shown in Table 7.
Comparative Example 13
[0212] Radiosterilization of a Protein Composition Containing SELP 8K
[0213] A protein composition according to Comparative Example 13 was produced as in Comparative Example 1, except that ascorbic acid as the radical scavenger was added in the proportion shown in Table 7.
Comparative Example 14
[0214] Radiosterilization of a Protein Composition Containing ProNectin F
[0215] A protein composition according to Comparative Example 14 was produced as in Comparative Example 2, except that ascorbic acid as the radical scavenger was added in the proportion shown in Table 7.
Comparative Example 15
[0216] Radiosterilization of a Protein Composition Containing ProNectin L
[0217] A protein composition according to Comparative Example 15 was produced as in Comparative Example 3, except that ascorbic acid as the radical scavenger was added in the proportion shown in Table 7.
Comparative Example 16
[0218] Radiosterilization of a Protein Composition Containing SELP 8K
[0219] A protein composition according to Comparative Example 16 was produced as in Comparative Example 1, except that tryptophan as the hydrogen-bond-formable compound (HC) was added in the proportion shown in Table 7.
Comparative Example 17
[0220] Radiosterilization of a Protein Composition Containing ProNectin F
[0221] A protein composition according to Comparative Example 17 was produced as in Comparative Example 2, except that tryptophan as the hydrogen-bond-formable compound (HC) was added in the proportion shown in Table 7.
Comparative Example 18
[0222] Radiosterilization of a Protein Composition Containing ProNectin L
[0223] A protein composition according to Comparative Example 18 was produced as in Comparative Example 3, except that tryptophan as the hydrogen-bond-formable compound (HC) was added in the proportion shown in Table 7.
<Evaluation of the Denaturation Rate Calculated Based on HPLC Measurement>
(HPLC Measurement)
[0224] The unsterilized protein composition prepared for the production of the protein composition in each example and the protein composition according to each example were separately dissolved in deionized water (1 mL) to obtain solutions each containing 1 mg of the protein (A), and these solutions were filtered through a 0.45-.mu.m filter to obtain test samples. Likewise, test samples of the unsterilized protein compositions prepared for the production of the protein compositions in the comparative examples and the protein compositions according to the comparative examples were prepared.
[0225] The test samples were measured by HPLC (Shimadzu Corporation) under the following conditions.
Column: Jupiter C4
Mobile Phase:
[0226] A: 99.85% by weight of water+0.15% by weight of trichloroacetic acid
[0227] B: 34% by weight of acetonitrile+65.85% by weight of water+0.15% by weight of trichloroacetic acid
[0228] C: 80% by weight of acetonitrile+19.85% by weight of water+0.15% by weight of trichloroacetic acid
Flow rate: 1 mL/min Mode: curved gradient mode (A/B=86/14 to A/B=20/80 to C=100) Measurement wavelength: 214 nm
(Calculation of Denaturation Rate Calculated Based on HPLC Measurement)
[0229] The denaturation rate calculated based on HPLC measurement was determined from the following formula (1), wherein M is the peak height of the unsterilized protein composition and N is the peak height of the produced protein composition as measured under the above conditions. Tables 3 to 7 show the results.
Denaturation rate (%)={1-(N/M)}.times.100 (1)
<Evaluation of the Denaturation Rate Calculated Based on LC-MSMS Measurement>
(LC-MSMS Measurement)
[0230] The unsterilized protein composition prepared for the production of the protein composition in each example and the protein composition according to each example were separately added to 6N hydrochloric acid (200 .mu.L) to obtain solutions each containing 1 mg of the protein (A), followed by degassing. Each of these solutions was degassed until foam was no longer formed, and then the protein (A) in each solution was hydrolyzed under vacuum sealed conditions at 110.degree. C. for 22 hours. After hydrolysis, each solution was diluted in deionized water to 800 .mu.L. Each diluted solution was filtered through a 0.45-.mu.m filter to obtain a test sample. Likewise, test samples of the unsterilized protein compositions prepared for the production of the protein compositions in the comparative examples and the protein compositions according to the comparative examples were prepared.
[0231] The test samples were analyzed by LC-MSMS (Shimadzu Corporation) under the following conditions.
Column: InertSustain C18 (GL Sciences Inc.)
Mobile Phase:
[0232] A: 0.05 M aqueous solution of trifluoroacetic acid
[0233] B: methanol
[0234] A/B=95/5 (V/V)
Flow rate: 0.2 mL/min Ion source: ESI (+) Measurement mode: MRM (MSMS)
[0235] The amino acid composition was determined from the elution time and the molecular weight of the standard sample (standard amino acid mixture: type H).
(Calculation of Denaturation Rate Calculated Based on LC-MSMS Measurement)
[0236] The denaturation rate calculated based on LC-MSMS measurement was determined from the following formula (2), wherein O.sub.n is the concentration of each amino acid in the unsterilized protein composition, P.sub.n is the concentration of each amino acid in the produced protein composition, and Q is the number of types of amino acids measured, which were determined under the above conditions. Tables 3 to 7 show the results.
Denaturation rate (%)=1/Q.times..SIGMA.[1-(P.sub.n/O.sub.n)].times.100 (2)
TABLE-US-00003 TABLE 3 Hydrogen-bond-formable Radical scavenger (RS) compound (HC) Denaturation {Weight ratio [(RS)/A]} {Molar ratio [(HC)/(A)]} rate (%) Protein Ascorbic Cate- Gallic Gluta- Chlorogenic Tryp- Tyro- Histi- LC- (A) acid Edaravone Vanillin chin acid thione acid tophan sine dine HPLC MSMS Example 1 SELP 8K 0.01 -- -- -- -- -- -- 0.01 -- -- 1 3 Example 2 SELP 8K 0.01 -- -- -- -- -- -- 0.02 -- -- 1 2 Example 3 SELP 8K 0.01 -- -- -- -- -- -- 0.05 -- -- 1 2 Example 4 SELP 8K 0.01 -- -- -- -- -- -- 0.50 -- -- 1 2 Example 5 SELP 8K 0.01 -- -- -- -- -- -- -- 0.01 -- 12 4 Example 6 SELP 8K 0.01 -- -- -- -- -- -- -- 0.02 -- 8 3 Example 7 SELP 8K 0.01 -- -- -- -- -- -- -- 0.05 -- 7 3 Example 8 SELP 8K 0.01 -- -- -- -- -- -- -- 0.50 -- 7 3 Example 9 SELP 8K 0.01 -- -- -- -- -- -- -- -- 0.01 10 8 Example 10 SELP 8K 0.01 -- -- -- -- -- -- -- -- 0.02 10 8 Example 11 SELP 8K 0.01 -- -- -- -- -- -- -- -- 0.05 9 4 Example 12 SELP 8K 0.01 -- -- -- -- -- -- -- -- 0.50 7 4 Example 13 SELP 8K 0.10 -- -- -- -- -- -- 0.02 -- -- 1 2 Example 14 SELP 8K 1.00 -- -- -- -- -- -- 0.02 -- -- 2 2 Example 15 SELP 8K -- 0.01 -- -- -- -- -- 0.02 -- -- 2 5 Example 16 SELP 8K -- 0.10 -- -- -- -- -- 0.02 -- -- 1 3 Example 17 SELP 8K -- 1.00 -- -- -- -- -- 0.02 -- -- 1 3 Example 18 SELP 8K -- -- 0.01 -- -- -- -- 0.02 -- -- 25 12 Example 19 SELP 8K -- -- 0.10 -- -- -- -- 0.02 -- -- 16 10 Example 20 SELP 8K -- -- 1.00 -- -- -- -- 0.02 -- -- 8 5 Example 21 SELP 8K -- -- -- 0.01 -- -- -- 0.02 -- -- 5 8 Example 22 SELP 8K -- -- -- 0.10 -- -- -- 0.02 -- -- 4 7 Example 23 SELP 8K -- -- -- 1.00 -- -- -- 0.02 -- -- 4 7 Example 24 SELP 8K -- -- -- -- 0.01 -- -- 0.02 -- -- 2 5 Example 25 SELP 8K -- -- -- -- 0.10 -- -- 0.02 -- -- 2 5 Example 26 SELP 8K -- -- -- -- 1.00 -- -- 0.02 -- -- 2 4 Example 27 SELP 8K -- -- -- -- -- 0.01 -- 0.02 -- -- 2 2 Example 28 SELP 8K -- -- -- -- -- 0.10 -- 0.02 -- -- 2 2 Example 29 SELP 8K -- -- -- -- -- 1.00 -- 0.02 -- -- 2 1 Example 30 SELP 8K -- -- -- -- -- -- 0.01 0.02 -- -- 15 8 Example 31 SELP 8K -- -- -- -- -- -- 0.10 0.02 -- -- 9 6 Example 32 SELP 8K -- -- -- -- -- -- 1.00 0.02 -- -- 6 5
TABLE-US-00004 TABLE 4 Hydrogen-bond-formable Radical scavenger (RS) compound (HC) Denaturation {Weight ratio [(RS)/A]} {Molar ratio [(HC)/(A)]} rate (%) Protein Ascorbic Cate- Gallic Gluta- Chlorogenic Tryp- Tyro- Histi- LC- (A) acid Edaravone Vanillin chin acid thione acid tophan sine dine HPLC MSMS Example 33 ProNectin F 0.01 -- -- -- -- -- -- 0.01 -- -- 2 4 Example 34 ProNectin F 0.01 -- -- -- -- -- -- 0.02 -- -- 2 4 Example 35 ProNectin F 0.01 -- -- -- -- -- -- 0.05 -- -- 1 3 Example 36 ProNectin F 0.01 -- -- -- -- -- -- 0.50 -- -- 1 3 Example 37 ProNectin F 0.01 -- -- -- -- -- -- -- 0.01 -- 15 4 Example 38 ProNectin F 0.01 -- -- -- -- -- -- -- 0.02 -- 12 3 Example 39 ProNectin F 0.01 -- -- -- -- -- -- -- 0.05 -- 11 3 Example 40 ProNectin F 0.01 -- -- -- -- -- -- -- 0.50 -- 4 3 Example 41 ProNectin F 0.01 -- -- -- -- -- -- -- -- 0.01 13 8 Example 42 ProNectin F 0.01 -- -- -- -- -- -- -- -- 0.02 12 7 Example 43 ProNectin F 0.01 -- -- -- -- -- -- -- -- 0.05 8 5 Example 44 ProNectin F 0.01 -- -- -- -- -- -- -- -- 0.50 8 5 Example 45 ProNectin F 0.10 -- -- -- -- -- -- 0.02 -- -- 2 3 Example 46 ProNectin F 1.00 -- -- -- -- -- -- 0.02 -- -- 2 3 Example 47 ProNectin F -- 0.001 -- -- -- -- -- 0.02 -- -- 25 12 Example 48 ProNectin F -- 0.01 -- -- -- -- -- 0.02 -- -- 1 2 Example 49 ProNectin F -- 0.10 -- -- -- -- -- 0.02 -- -- 1 1 Example 50 ProNectin F -- 1.00 -- -- -- -- -- 0.02 -- -- 1 1 Example 51 ProNectin F -- -- 0.01 -- -- -- -- 0.02 -- -- 28 5 Example 52 ProNectin F -- -- 0.10 -- -- -- -- 0.02 -- -- 15 3 Example 53 ProNectin F -- -- 1.00 -- -- -- -- 0.02 -- -- 12 2 Example 54 ProNectin F -- -- -- 0.01 -- -- -- 0.02 -- -- 5 7 Example 55 ProNectin F -- -- -- 0.10 -- -- -- 0.02 -- -- 3 6 Example 56 ProNectin F -- -- -- 1.00 -- -- -- 0.02 -- -- 3 6 Example 57 ProNectin F -- -- -- -- 0.01 -- -- 0.02 -- -- 2 3 Example 58 ProNectin F -- -- -- -- 0.10 -- -- 0.02 -- -- 1 2 Example 59 ProNectin F -- -- -- -- 1.00 -- -- 0.02 -- -- 1 2 Example 60 ProNectin F -- -- -- -- -- 0.01 -- 0.02 -- -- 21 4 Example 61 ProNectin F -- -- -- -- -- 0.10 -- 0.02 -- -- 14 3 Example 62 ProNectin F -- -- -- -- -- 1.00 -- 0.02 -- -- 11 3 Example 63 ProNectin F -- -- -- -- -- -- 0.01 0.02 -- -- 18 4 Example 64 ProNectin F -- -- -- -- -- -- 0.10 0.02 -- -- 12 3 Example 65 ProNectin F -- -- -- -- -- -- 1.00 0.02 -- -- 11 3
TABLE-US-00005 TABLE 5 Hydrogen-bond-formable Radical scavenger (RS) compound (HC) Denaturation [Weight ratio [(RS)/A]} [Molar ratio [(HC)/(A)]} rate (%) Protein Ascorbic Cate- Gallic Gluta- Chlorogenic Tryp- Tyro- Histi- LC- (A) acid Edaravone Vanillin chin acid thione acid tophan sine dine HPLC MSMS Example 66 ProNectin L 0.01 -- -- -- -- -- -- 0.01 -- -- 1 6 Example 67 ProNectin L 0.01 -- -- -- -- -- -- 0.02 -- -- 1 5 Example 68 ProNectin L 0.01 -- -- -- -- -- -- 0.05 -- -- 1 5 Example 69 ProNectin L 0.01 -- -- -- -- -- -- 0.50 -- -- 1 5 Example 70 ProNectin L 0.01 -- -- -- -- -- -- -- 0.01 -- 20 5 Example 71 ProNectin L 0.01 -- -- -- -- -- -- -- 0.02 -- 19 4 Example 72 ProNectin L 0.01 -- -- -- -- -- -- -- 0.05 -- 15 4 Example 73 ProNectin L 0.01 -- -- -- -- -- -- -- 0.50 -- 11 5 Example 74 ProNectin L 0.01 -- -- -- -- -- -- -- -- 0.01 18 9 Example 75 ProNectin L 0.01 -- -- -- -- -- -- -- -- 0.02 17 6 Example 76 ProNectin L 0.01 -- -- -- -- -- -- -- -- 0.05 12 5 Example 77 ProNectin L 0.01 -- -- -- -- -- -- -- -- 0.50 10 5 Example 78 ProNectin L 0.10 -- -- -- -- -- -- 0.02 -- -- 1 5 Example 79 ProNectin L 1.00 -- -- -- -- -- -- 0.02 -- -- 1 5 Example 80 ProNectin L -- 0.01 -- -- -- -- -- 0.02 -- -- 1 4 Example 81 ProNectin L -- 0.10 -- -- -- -- -- 0.02 -- -- 1 4 Example 82 ProNectin L -- 1.00 -- -- -- -- -- 0.02 -- -- 1 3 Example 83 ProNectin L -- -- 0.01 -- -- -- -- 0.02 -- -- 26 5 Example 84 ProNectin L -- -- 0.10 -- -- -- -- 0.02 -- -- 11 3 Example 85 ProNectin L -- -- 1.00 -- -- -- -- 0.02 -- -- 10 3 Example 86 ProNectin L -- -- -- 0.01 -- -- -- 0.02 -- -- 2 7 Example 87 ProNectin L -- -- -- 0.10 -- -- -- 0.02 -- -- 2 7 Example 88 ProNectin L -- -- -- 1.00 -- -- -- 0.02 -- -- 2 5 Example 89 ProNectin L -- -- -- -- 0.01 -- -- 0.02 -- -- 1 5 Example 90 ProNectin L -- -- -- -- 0.10 -- -- 0.02 -- -- 1 5 Example 91 ProNectin L -- -- -- -- 1.00 -- -- 0.02 -- -- 1 4 Example 92 ProNectin L -- -- -- -- -- 0.01 -- 0.02 -- -- 10 6 Example 93 ProNectin L -- -- -- -- -- 0.10 -- 0.02 -- -- 7 5 Example 94 ProNectin L -- -- -- -- -- 1.00 -- 0.02 -- -- 7 5 Example 95 ProNectin L -- -- -- -- -- -- 0.01 0.02 -- -- 7 5 Example 96 ProNectin L -- -- -- -- -- -- 0.10 0.02 -- -- 6 5 Example 97 ProNectin L -- -- -- -- -- -- 1.00 0.02 -- -- 5 4
TABLE-US-00006 TABLE 6 Hydrogen-bond-formable Radical scavenger (RS) compound (HC) Denaturation {Weight ratio [(RS)/A]} {Molar ratio [(HC)/(A)]} rate (%) Protein Ascorbic Cate- Gallic Gluta- Chlorogenic Tryp- Tyro- Histi- LC- (A) acid Edaravone Vanillin chin acid thione acid tophan sine dine HPLC MSMS Example 98 HRP-conju- 0.01 -- -- -- -- -- -- 0.02 -- -- 22 5 gated rabbit antibody Example 99 Glucose 0.01 -- -- -- -- -- -- 0.02 -- -- 12 5 oxidase Example 100 Bovine se- 0.01 -- -- -- -- -- -- 0.02 -- -- 7 4 rum albumin
TABLE-US-00007 TABLE 7 Hydrogen-bond-formable Radical scavenger (RS) compound (HC) Denaturation {Weight ratio [(RS)/A]} {Molar ratio [(HC)/(A)]} rate (%) Protein Ascorbic Cate- Gallic Gluta- Chlorogenic Tryp- Tyro- Histi- LC- (A) acid Edaravone Vanillin chin acid thione acid tophan sine dine HPLC MSMS Comparative SELP 8K -- -- -- -- -- -- -- -- -- -- 30 15 Example 1 Comparative ProNectin F -- -- -- -- -- -- -- -- -- -- 50 10 Example 2 Comparative ProNectin L -- -- -- -- -- -- -- -- -- -- 45 12 Example 3 Comparative HRP-conju- -- -- -- -- -- -- -- -- -- -- 85 22 Example 4 gated rabbit antibody Comparative Glucose -- -- -- -- -- -- -- -- -- -- 70 18 Example 5 oxidase Comparative Bovine se- -- -- -- -- -- -- -- -- -- -- 62 10 Example 6 rum albumin Comparative SELP 8K 0.01 -- -- -- -- -- -- -- -- -- 29 15 Example 7 Comparative ProNectin F 0.01 -- -- -- -- -- -- -- -- -- 48 11 Example 8 Comparative ProNectin L 0.01 -- -- -- -- -- -- -- -- -- 42 10 Example 9 Comparative HRP-conju- 0.01 -- -- -- -- -- -- -- -- -- 83 19 Example 10 gated rabbit antibody Comparative Glucose 0.01 -- -- -- -- -- -- -- -- -- 66 18 Example 11 oxidase Comparative Bovine se- 0.01 -- -- -- -- -- -- -- -- -- 60 10 Example 12 rum albumin Comparative SELP 8K 0.001 -- -- -- -- -- -- -- -- -- 28 12 Example 13 Comparative ProNectin F 0.001 -- -- -- -- -- -- -- -- -- 49 11 Example 14 Comparative ProNectin L 0.001 -- -- -- -- -- -- -- -- -- 42 10 Example 15 Comparative SELP 8K -- -- -- -- -- -- -- 0.005 -- -- 28 12 Example 16 Comparative ProNectin F -- -- -- -- -- -- -- 0.005 -- -- 49 16 Example 17 Comparative ProNectin L -- -- -- -- -- -- -- 0.005 -- -- 44 12 Example 18
[0237] The results in Tables 3 to 7 show that the denaturation rate of the protein (A) is lower in each of the protein compositions obtained by the production method of the present invention than that in the protein compositions according to Comparative Examples 1 to 18.
INDUSTRIAL APPLICABILITY
[0238] The method for producing a protein composition of the present invention is excellent in allowing a protein composition to maintain physiological and physicochemical functions of a protein when the protein composition is subjected to radiosterilization. Thus, the present invention is effective as a method for producing a protein composition.
[0239] SEQUENCE LISTING FREE TEXT
Sequence CWU
1
1
3516PRTBombyx mori 1Gly Ala Gly Ala Gly Ser 1 5
25PRTHomo sapiens 2Tyr Ile Gly Ser Arg 1 5 35PRTHomo
sapiens 3Gly Val Gly Val Pro 1 5 45PRTHomo sapiens 4Pro
Gly Val Gly Val 1 5 55PRTHomo sapiens 5Val Pro Gly Val
Gly 1 5 65PRTHomo sapiens 6Gly Val Pro Gly Val 1
5 75PRTHomo sapiens 7Val Gly Val Pro Gly 1 5
89PRTHomo sapiens 8Gly Ala His Gly Pro Ala Gly Pro Lys 1 5
95PRTBombyx mori 9Val Ala Ala Gly Tyr 1 5
107PRTBombyx mori 10Gly Ala Gly Ala Gly Ala Ser 1 5
116PRTHomo sapiens 11Leu Gly Pro Leu Gly Pro 1 5
129PRTHomo sapiens 12Gly Ala His Gly Pro Ala Gly Pro Lys 1
5 1318PRTHomo sapiens 13Gly Ala Pro Gly Pro Ala Gly Pro
Pro Gly Ser Arg Gly Asp Pro Gly 1 5 10
15 Pro Pro 149PRTHomo sapiens 14Gly Ala Gln Gly Pro
Ala Gly Pro Gly 1 5 1515PRTHomo sapiens
15Gly Ala Pro Gly Ala Pro Gly Ser Gln Gly Ala Pro Gly Leu Gln 1
5 10 15 1615PRTHomo sapiens 16Gly
Ala Pro Gly Thr Pro Gly Pro Gln Gly Leu Pro Gly Ser Pro 1 5
10 15 1717PRTHomo sapiens 17Gly Ala
Ala Val Thr Gly Arg Gly Asp Ser Pro Ala Ser Ala Ala Gly 1 5
10 15 Tyr 1820PRTHomo sapiens
18Gly Ala Ala Pro Gly Ala Ser Ile Lys Val Ala Val Ser Ala Gly Pro 1
5 10 15 Ser Ala Gly Tyr
20 1924PRTArtificial SequenceRepeat sequence 19Gly Ala Gly Ala
Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala 1 5
10 15 Gly Ser Gly Ala Gly Ala Gly Ser
20 2040PRTArtificial SequenceRepeat sequence
20Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly 1
5 10 15 Val Gly Val Pro
Gly Lys Gly Val Pro Gly Val Gly Val Pro Gly Val 20
25 30 Gly Val Pro Gly Val Gly Val Pro
35 40 2112PRTArtificial SequenceRepeat sequence
21Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser 1 5
10 22874PRTArtificial SequenceSELP8K 22Met Asp Pro
Val Val Leu Gln Arg Arg Asp Trp Glu Asn Pro Gly Val 1 5
10 15 Thr Gln Leu Asn Arg Leu Ala Ala
His Pro Pro Phe Ala Ser Asp Pro 20 25
30 Met Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val
Gly Val Pro 35 40 45
Gly Val Gly Val Pro Gly Lys Gly Val Pro Gly Val Gly Val Pro Gly 50
55 60 Val Gly Val Pro
Gly Val Gly Val Pro Gly Ala Gly Ala Gly Ser Gly 65 70
75 80 Ala Gly Ala Gly Ser Gly Ala Gly Ala
Gly Ser Gly Ala Gly Ala Gly 85 90
95 Ser Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly
Val Pro 100 105 110
Gly Val Gly Val Pro Gly Lys Gly Val Pro Gly Val Gly Val Pro Gly
115 120 125 Val Gly Val Pro
Gly Val Gly Val Pro Gly Ala Gly Ala Gly Ser Gly 130
135 140 Ala Gly Ala Gly Ser Gly Ala Gly
Ala Gly Ser Gly Ala Gly Ala Gly 145 150
155 160 Ser Gly Val Gly Val Pro Gly Val Gly Val Pro Gly
Val Gly Val Pro 165 170
175 Gly Val Gly Val Pro Gly Lys Gly Val Pro Gly Val Gly Val Pro Gly
180 185 190 Val Gly Val
Pro Gly Val Gly Val Pro Gly Ala Gly Ala Gly Ser Gly 195
200 205 Ala Gly Ala Gly Ser Gly Ala Gly
Ala Gly Ser Gly Ala Gly Ala Gly 210 215
220 Ser Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val
Gly Val Pro 225 230 235
240 Gly Val Gly Val Pro Gly Lys Gly Val Pro Gly Val Gly Val Pro Gly
245 250 255 Val Gly Val Pro
Gly Val Gly Val Pro Gly Ala Gly Ala Gly Ser Gly 260
265 270 Ala Gly Ala Gly Ser Gly Ala Gly Ala
Gly Ser Gly Ala Gly Ala Gly 275 280
285 Ser Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly
Val Pro 290 295 300
Gly Val Gly Val Pro Gly Lys Gly Val Pro Gly Val Gly Val Pro Gly 305
310 315 320 Val Gly Val Pro Gly
Val Gly Val Pro Gly Ala Gly Ala Gly Ser Gly 325
330 335 Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly
Ser Gly Ala Gly Ala Gly 340 345
350 Ser Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val
Pro 355 360 365 Gly
Val Gly Val Pro Gly Lys Gly Val Pro Gly Val Gly Val Pro Gly 370
375 380 Val Gly Val Pro Gly Val
Gly Val Pro Gly Ala Gly Ala Gly Ser Gly 385 390
395 400 Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser
Gly Ala Gly Ala Gly 405 410
415 Ser Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro
420 425 430 Gly Val
Gly Val Pro Gly Lys Gly Val Pro Gly Val Gly Val Pro Gly 435
440 445 Val Gly Val Pro Gly Val Gly
Val Pro Gly Ala Gly Ala Gly Ser Gly 450 455
460 Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly
Ala Gly Ala Gly 465 470 475
480 Ser Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro
485 490 495 Gly Val Gly
Val Pro Gly Lys Gly Val Pro Gly Val Gly Val Pro Gly 500
505 510 Val Gly Val Pro Gly Val Gly Val
Pro Gly Ala Gly Ala Gly Ser Gly 515 520
525 Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala
Gly Ala Gly 530 535 540
Ser Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro 545
550 555 560 Gly Val Gly Val
Pro Gly Lys Gly Val Pro Gly Val Gly Val Pro Gly 565
570 575 Val Gly Val Pro Gly Val Gly Val Pro
Gly Ala Gly Ala Gly Ser Gly 580 585
590 Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly
Ala Gly 595 600 605
Ser Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro 610
615 620 Gly Val Gly Val Pro
Gly Lys Gly Val Pro Gly Val Gly Val Pro Gly 625 630
635 640 Val Gly Val Pro Gly Val Gly Val Pro Gly
Ala Gly Ala Gly Ser Gly 645 650
655 Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala
Gly 660 665 670 Ser
Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro 675
680 685 Gly Val Gly Val Pro Gly
Lys Gly Val Pro Gly Val Gly Val Pro Gly 690 695
700 Val Gly Val Pro Gly Val Gly Val Pro Gly Ala
Gly Ala Gly Ser Gly 705 710 715
720 Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly
725 730 735 Ser Gly
Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro 740
745 750 Gly Val Gly Val Pro Gly Lys
Gly Val Pro Gly Val Gly Val Pro Gly 755 760
765 Val Gly Val Pro Gly Val Gly Val Pro Gly Ala Gly
Ala Gly Ser Gly 770 775 780
Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly 785
790 795 800 Ser Gly Val
Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro 805
810 815 Gly Val Gly Val Pro Gly Lys Gly
Val Pro Gly Val Gly Val Pro Gly 820 825
830 Val Gly Val Pro Gly Val Gly Val Pro Gly Ala Gly Ala
Gly Ser Gly 835 840 845
Ala Gly Ala Gly Ser Gly Ala Gly Ala Met Asp Pro Gly Arg Tyr Gln 850
855 860 Asp Leu Arg Ser
His His His His His His 865 870
23938PRTArtificial SequenceSELP0K 23Met Asp Pro Val Val Leu Gln Arg Arg
Asp Trp Glu Asn Pro Gly Val 1 5 10
15 Thr Gln Leu Asn Arg Leu Ala Ala His Pro Pro Phe Ala Ser
Asp Pro 20 25 30
Met Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro
35 40 45 Gly Val Gly Val
Pro Gly Lys Gly Val Pro Gly Val Gly Val Pro Gly 50
55 60 Val Gly Val Pro Gly Val Gly Val
Pro Gly Ala Gly Ala Gly Ser Gly 65 70
75 80 Ala Gly Ala Gly Ser Gly Val Gly Val Pro Gly Val
Gly Val Pro Gly 85 90
95 Val Gly Val Pro Gly Val Gly Val Pro Gly Lys Gly Val Pro Gly Val
100 105 110 Gly Val Pro
Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Ala Gly 115
120 125 Ala Gly Ser Gly Ala Gly Ala Gly
Ser Gly Val Gly Val Pro Gly Val 130 135
140 Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro
Gly Lys Gly 145 150 155
160 Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val
165 170 175 Pro Gly Ala Gly
Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Val Gly 180
185 190 Val Pro Gly Val Gly Val Pro Gly Val
Gly Val Pro Gly Val Gly Val 195 200
205 Pro Gly Lys Gly Val Pro Gly Val Gly Val Pro Gly Val Gly
Val Pro 210 215 220
Gly Val Gly Val Pro Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly 225
230 235 240 Ser Gly Val Gly Val
Pro Gly Val Gly Val Pro Gly Val Gly Val Pro 245
250 255 Gly Val Gly Val Pro Gly Lys Gly Val Pro
Gly Val Gly Val Pro Gly 260 265
270 Val Gly Val Pro Gly Val Gly Val Pro Gly Ala Gly Ala Gly Ser
Gly 275 280 285 Ala
Gly Ala Gly Ser Gly Val Gly Val Pro Gly Val Gly Val Pro Gly 290
295 300 Val Gly Val Pro Gly Val
Gly Val Pro Gly Lys Gly Val Pro Gly Val 305 310
315 320 Gly Val Pro Gly Val Gly Val Pro Gly Val Gly
Val Pro Gly Ala Gly 325 330
335 Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Val Gly Val Pro Gly Val
340 345 350 Gly Val
Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Lys Gly 355
360 365 Val Pro Gly Val Gly Val Pro
Gly Val Gly Val Pro Gly Val Gly Val 370 375
380 Pro Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly
Ser Gly Val Gly 385 390 395
400 Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val
405 410 415 Pro Gly Lys
Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro 420
425 430 Gly Val Gly Val Pro Gly Ala Gly
Ala Gly Ser Gly Ala Gly Ala Gly 435 440
445 Ser Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val
Gly Val Pro 450 455 460
Gly Val Gly Val Pro Gly Lys Gly Val Pro Gly Val Gly Val Pro Gly 465
470 475 480 Val Gly Val Pro
Gly Val Gly Val Pro Gly Ala Gly Ala Gly Ser Gly 485
490 495 Ala Gly Ala Gly Ser Gly Val Gly Val
Pro Gly Val Gly Val Pro Gly 500 505
510 Val Gly Val Pro Gly Val Gly Val Pro Gly Lys Gly Val Pro
Gly Val 515 520 525
Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Ala Gly 530
535 540 Ala Gly Ser Gly Ala
Gly Ala Gly Ser Gly Val Gly Val Pro Gly Val 545 550
555 560 Gly Val Pro Gly Val Gly Val Pro Gly Val
Gly Val Pro Gly Lys Gly 565 570
575 Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly
Val 580 585 590 Pro
Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Val Gly 595
600 605 Val Pro Gly Val Gly Val
Pro Gly Val Gly Val Pro Gly Val Gly Val 610 615
620 Pro Gly Lys Gly Val Pro Gly Val Gly Val Pro
Gly Val Gly Val Pro 625 630 635
640 Gly Val Gly Val Pro Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly
645 650 655 Ser Gly
Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro 660
665 670 Gly Val Gly Val Pro Gly Lys
Gly Val Pro Gly Val Gly Val Pro Gly 675 680
685 Val Gly Val Pro Gly Val Gly Val Pro Gly Ala Gly
Ala Gly Ser Gly 690 695 700
Ala Gly Ala Gly Ser Gly Val Gly Val Pro Gly Val Gly Val Pro Gly 705
710 715 720 Val Gly Val
Pro Gly Val Gly Val Pro Gly Lys Gly Val Pro Gly Val 725
730 735 Gly Val Pro Gly Val Gly Val Pro
Gly Val Gly Val Pro Gly Ala Gly 740 745
750 Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Val Gly Val
Pro Gly Val 755 760 765
Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Lys Gly 770
775 780 Val Pro Gly Val
Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val 785 790
795 800 Pro Gly Ala Gly Ala Gly Ser Gly Ala
Gly Ala Gly Ser Gly Val Gly 805 810
815 Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val
Gly Val 820 825 830
Pro Gly Lys Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro
835 840 845 Gly Val Gly Val
Pro Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly 850
855 860 Ser Gly Val Gly Val Pro Gly Val
Gly Val Pro Gly Val Gly Val Pro 865 870
875 880 Gly Val Gly Val Pro Gly Lys Gly Val Pro Gly Val
Gly Val Pro Gly 885 890
895 Val Gly Val Pro Gly Val Gly Val Pro Gly Ala Gly Ala Gly Ser Gly
900 905 910 Ala Gly Ala
Gly Ser Gly Ala Gly Ala Met Asp Pro Gly Arg Tyr Gln 915
920 925 Asp Leu Arg Ser His His His His
His His 930 935 2460PRTArtificial
SequenceRepeat sequence 24Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val
Gly Val Pro Gly 1 5 10
15 Val Gly Val Pro Gly Lys Gly Val Pro Gly Val Gly Val Pro Gly Val
20 25 30 Gly Val Pro
Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly 35
40 45 Val Pro Gly Val Gly Val Pro Gly
Val Gly Val Pro 50 55 60
25886PRTArtificial SequenceSELP415K 25Met Asp Pro Val Val Leu Gln Arg Arg
Asp Trp Glu Asn Pro Gly Val 1 5 10
15 Thr Gln Leu Asn Arg Leu Ala Ala His Pro Pro Phe Ala Ser
Asp Pro 20 25 30
Met Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Val Gly
35 40 45 Val Pro Gly Val
Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val 50
55 60 Pro Gly Lys Gly Val Pro Gly Val
Gly Val Pro Gly Val Gly Val Pro 65 70
75 80 Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val
Gly Val Pro Gly 85 90
95 Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val
100 105 110 Gly Val Pro
Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Ala Gly 115
120 125 Ala Gly Ser Gly Ala Gly Ala Gly
Ser Gly Ala Gly Ala Gly Ser Gly 130 135
140 Ala Gly Ala Gly Ser Gly Val Gly Val Pro Gly Val Gly
Val Pro Gly 145 150 155
160 Val Gly Val Pro Gly Val Gly Val Pro Gly Lys Gly Val Pro Gly Val
165 170 175 Gly Val Pro Gly
Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly 180
185 190 Val Pro Gly Val Gly Val Pro Gly Val
Gly Val Pro Gly Val Gly Val 195 200
205 Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly
Val Pro 210 215 220
Gly Val Gly Val Pro Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly 225
230 235 240 Ser Gly Ala Gly Ala
Gly Ser Gly Ala Gly Ala Gly Ser Gly Val Gly 245
250 255 Val Pro Gly Val Gly Val Pro Gly Val Gly
Val Pro Gly Val Gly Val 260 265
270 Pro Gly Lys Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val
Pro 275 280 285 Gly
Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly 290
295 300 Val Gly Val Pro Gly Val
Gly Val Pro Gly Val Gly Val Pro Gly Val 305 310
315 320 Gly Val Pro Gly Val Gly Val Pro Gly Val Gly
Val Pro Gly Ala Gly 325 330
335 Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly
340 345 350 Ala Gly
Ala Gly Ser Gly Val Gly Val Pro Gly Val Gly Val Pro Gly 355
360 365 Val Gly Val Pro Gly Val Gly
Val Pro Gly Lys Gly Val Pro Gly Val 370 375
380 Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val
Pro Gly Val Gly 385 390 395
400 Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val
405 410 415 Pro Gly Val
Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro 420
425 430 Gly Val Gly Val Pro Gly Ala Gly
Ala Gly Ser Gly Ala Gly Ala Gly 435 440
445 Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser
Gly Val Gly 450 455 460
Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val 465
470 475 480 Pro Gly Lys Gly
Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro 485
490 495 Gly Val Gly Val Pro Gly Val Gly Val
Pro Gly Val Gly Val Pro Gly 500 505
510 Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro
Gly Val 515 520 525
Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Ala Gly 530
535 540 Ala Gly Ser Gly Ala
Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly 545 550
555 560 Ala Gly Ala Gly Ser Gly Val Gly Val Pro
Gly Val Gly Val Pro Gly 565 570
575 Val Gly Val Pro Gly Val Gly Val Pro Gly Lys Gly Val Pro Gly
Val 580 585 590 Gly
Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly 595
600 605 Val Pro Gly Val Gly Val
Pro Gly Val Gly Val Pro Gly Val Gly Val 610 615
620 Pro Gly Val Gly Val Pro Gly Val Gly Val Pro
Gly Val Gly Val Pro 625 630 635
640 Gly Val Gly Val Pro Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly
645 650 655 Ser Gly
Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Val Gly 660
665 670 Val Pro Gly Val Gly Val Pro
Gly Val Gly Val Pro Gly Val Gly Val 675 680
685 Pro Gly Lys Gly Val Pro Gly Val Gly Val Pro Gly
Val Gly Val Pro 690 695 700
Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly 705
710 715 720 Val Gly Val
Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val 725
730 735 Gly Val Pro Gly Val Gly Val Pro
Gly Val Gly Val Pro Gly Ala Gly 740 745
750 Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala
Gly Ser Gly 755 760 765
Ala Gly Ala Gly Ser Gly Val Gly Val Pro Gly Val Gly Val Pro Gly 770
775 780 Val Gly Val Pro
Gly Val Gly Val Pro Gly Lys Gly Val Pro Gly Val 785 790
795 800 Gly Val Pro Gly Val Gly Val Pro Gly
Val Gly Val Pro Gly Val Gly 805 810
815 Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val
Gly Val 820 825 830
Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro
835 840 845 Gly Val Gly Val
Pro Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly 850
855 860 Ser Gly Ala Gly Ala Met Asp Pro
Gly Arg Tyr Gln Asp Leu Arg Ser 865 870
875 880 His His His His His His 885
26750PRTArtificial SequenceSELP815K 26Met Asp Pro Val Val Leu Gln Arg Arg
Asp Trp Glu Asn Pro Gly Val 1 5 10
15 Thr Gln Leu Asn Arg Leu Ala Ala His Pro Pro Phe Ala Ser
Asp Pro 20 25 30
Met Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Val Gly
35 40 45 Val Pro Gly Val
Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val 50
55 60 Pro Gly Lys Gly Val Pro Gly Val
Gly Val Pro Gly Val Gly Val Pro 65 70
75 80 Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val
Gly Val Pro Gly 85 90
95 Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val
100 105 110 Gly Val Pro
Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Ala Gly 115
120 125 Ala Gly Ser Gly Ala Gly Ala Gly
Ser Gly Ala Gly Ala Gly Ser Gly 130 135
140 Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala
Gly Ala Gly 145 150 155
160 Ser Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro
165 170 175 Gly Val Gly Val
Pro Gly Lys Gly Val Pro Gly Val Gly Val Pro Gly 180
185 190 Val Gly Val Pro Gly Val Gly Val Pro
Gly Val Gly Val Pro Gly Val 195 200
205 Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly
Val Gly 210 215 220
Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val 225
230 235 240 Pro Gly Ala Gly Ala
Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly 245
250 255 Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly
Ala Gly Ala Gly Ser Gly 260 265
270 Ala Gly Ala Gly Ser Gly Val Gly Val Pro Gly Val Gly Val Pro
Gly 275 280 285 Val
Gly Val Pro Gly Val Gly Val Pro Gly Lys Gly Val Pro Gly Val 290
295 300 Gly Val Pro Gly Val Gly
Val Pro Gly Val Gly Val Pro Gly Val Gly 305 310
315 320 Val Pro Gly Val Gly Val Pro Gly Val Gly Val
Pro Gly Val Gly Val 325 330
335 Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro
340 345 350 Gly Val
Gly Val Pro Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly 355
360 365 Ser Gly Ala Gly Ala Gly Ser
Gly Ala Gly Ala Gly Ser Gly Ala Gly 370 375
380 Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Val Gly
Val Pro Gly Val 385 390 395
400 Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Lys Gly
405 410 415 Val Pro Gly
Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val 420
425 430 Pro Gly Val Gly Val Pro Gly Val
Gly Val Pro Gly Val Gly Val Pro 435 440
445 Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly
Val Pro Gly 450 455 460
Val Gly Val Pro Gly Val Gly Val Pro Gly Ala Gly Ala Gly Ser Gly 465
470 475 480 Ala Gly Ala Gly
Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly 485
490 495 Ser Gly Ala Gly Ala Gly Ser Gly Ala
Gly Ala Gly Ser Gly Val Gly 500 505
510 Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val
Gly Val 515 520 525
Pro Gly Lys Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro 530
535 540 Gly Val Gly Val Pro
Gly Val Gly Val Pro Gly Val Gly Val Pro Gly 545 550
555 560 Val Gly Val Pro Gly Val Gly Val Pro Gly
Val Gly Val Pro Gly Val 565 570
575 Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Ala
Gly 580 585 590 Ala
Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly 595
600 605 Ala Gly Ala Gly Ser Gly
Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly 610 615
620 Ser Gly Val Gly Val Pro Gly Val Gly Val Pro
Gly Val Gly Val Pro 625 630 635
640 Gly Val Gly Val Pro Gly Lys Gly Val Pro Gly Val Gly Val Pro Gly
645 650 655 Val Gly
Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val 660
665 670 Gly Val Pro Gly Val Gly Val
Pro Gly Val Gly Val Pro Gly Val Gly 675 680
685 Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro
Gly Val Gly Val 690 695 700
Pro Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly 705
710 715 720 Ala Gly Ser
Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Met Asp Pro 725
730 735 Gly Arg Tyr Gln Asp Leu Arg Ser
His His His His His His 740 745
750 2736PRTArtificial SequenceRepeat sequence 27Gly Ala Gly Ala Gly Ser
Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala 1 5
10 15 Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly
Ala Gly Ser Gly Ala 20 25
30 Gly Ala Gly Ser 35 2854PRTArtificial
SequenceRepeat sequence 28Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser
Gly Ala Gly Ala 1 5 10
15 Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala
20 25 30 Gly Ala Gly
Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser 35
40 45 Gly Ala Gly Ala Gly Ser 50
29852PRTArtificial SequenceRepeat sequence 29Gly Ala Gly
Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala 1 5
10 15 Gly Ser Gly Ala Gly Ala Gly Ser
Gly Ala Gly Ala Gly Ser Gly Ala 20 25
30 Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly
Ala Gly Ser 35 40 45
Gly Ala Gly Ala Gly Ser Gly Ala Ala Val Thr Gly Arg Gly Asp Ser 50
55 60 Pro Ala Ser Ala
Ala Gly Tyr Gly Ala Gly Ala Gly Ser Gly Ala Gly 65 70
75 80 Ala Gly Ser Gly Ala Gly Ala Gly Ser
Gly Ala Gly Ala Gly Ser Gly 85 90
95 Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly
Ala Gly 100 105 110
Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Ala
115 120 125 Val Thr Gly Arg
Gly Asp Ser Pro Ala Ser Ala Ala Gly Tyr Gly Ala 130
135 140 Gly Ala Gly Ser Gly Ala Gly Ala
Gly Ser Gly Ala Gly Ala Gly Ser 145 150
155 160 Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser
Gly Ala Gly Ala 165 170
175 Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala
180 185 190 Gly Ala Gly
Ser Gly Ala Ala Val Thr Gly Arg Gly Asp Ser Pro Ala 195
200 205 Ser Ala Ala Gly Tyr Gly Ala Gly
Ala Gly Ser Gly Ala Gly Ala Gly 210 215
220 Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser
Gly Ala Gly 225 230 235
240 Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly
245 250 255 Ala Gly Ala Gly
Ser Gly Ala Gly Ala Gly Ser Gly Ala Ala Val Thr 260
265 270 Gly Arg Gly Asp Ser Pro Ala Ser Ala
Ala Gly Tyr Gly Ala Gly Ala 275 280
285 Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser
Gly Ala 290 295 300
Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser 305
310 315 320 Gly Ala Gly Ala Gly
Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala 325
330 335 Gly Ser Gly Ala Ala Val Thr Gly Arg Gly
Asp Ser Pro Ala Ser Ala 340 345
350 Ala Gly Tyr Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser
Gly 355 360 365 Ala
Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly 370
375 380 Ser Gly Ala Gly Ala Gly
Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly 385 390
395 400 Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala
Ala Val Thr Gly Arg 405 410
415 Gly Asp Ser Pro Ala Ser Ala Ala Gly Tyr Gly Ala Gly Ala Gly Ser
420 425 430 Gly Ala
Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala 435
440 445 Gly Ser Gly Ala Gly Ala Gly
Ser Gly Ala Gly Ala Gly Ser Gly Ala 450 455
460 Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala
Gly Ala Gly Ser 465 470 475
480 Gly Ala Ala Val Thr Gly Arg Gly Asp Ser Pro Ala Ser Ala Ala Gly
485 490 495 Tyr Gly Ala
Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly 500
505 510 Ala Gly Ser Gly Ala Gly Ala Gly
Ser Gly Ala Gly Ala Gly Ser Gly 515 520
525 Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala
Gly Ala Gly 530 535 540
Ser Gly Ala Gly Ala Gly Ser Gly Ala Ala Val Thr Gly Arg Gly Asp 545
550 555 560 Ser Pro Ala Ser
Ala Ala Gly Tyr Gly Ala Gly Ala Gly Ser Gly Ala 565
570 575 Gly Ala Gly Ser Gly Ala Gly Ala Gly
Ser Gly Ala Gly Ala Gly Ser 580 585
590 Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala
Gly Ala 595 600 605
Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala 610
615 620 Ala Val Thr Gly Arg
Gly Asp Ser Pro Ala Ser Ala Ala Gly Tyr Gly 625 630
635 640 Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly
Ser Gly Ala Gly Ala Gly 645 650
655 Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala
Gly 660 665 670 Ala
Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly 675
680 685 Ala Gly Ala Gly Ser Gly
Ala Ala Val Thr Gly Arg Gly Asp Ser Pro 690 695
700 Ala Ser Ala Ala Gly Tyr Gly Ala Gly Ala Gly
Ser Gly Ala Gly Ala 705 710 715
720 Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala
725 730 735 Gly Ala
Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser 740
745 750 Gly Ala Gly Ala Gly Ser Gly
Ala Gly Ala Gly Ser Gly Ala Ala Val 755 760
765 Thr Gly Arg Gly Asp Ser Pro Ala Ser Ala Ala Gly
Tyr Gly Ala Gly 770 775 780
Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly 785
790 795 800 Ala Gly Ala
Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly 805
810 815 Ser Gly Ala Gly Ala Gly Ser Gly
Ala Gly Ala Gly Ser Gly Ala Gly 820 825
830 Ala Gly Ser Gly Ala Ala Val Thr Gly Arg Gly Asp Ser
Pro Ala Ser 835 840 845
Ala Ala Gly Tyr 850 30980PRTArtificial SequencePronectinF
30Met Asp Pro Val Val Leu Gln Arg Arg Asp Trp Glu Asn Pro Gly Val 1
5 10 15 Thr Gln Leu Asn
Arg Leu Ala Ala His Pro Pro Phe Ala Ser Asp Pro 20
25 30 Met Gly Ala Gly Ser Gly Ala Gly Ala
Gly Ser Gly Ala Gly Ala Gly 35 40
45 Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly
Ala Gly 50 55 60
Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Ala Val Thr Gly Arg 65
70 75 80 Gly Asp Ser Pro Ala
Ser Ala Ala Gly Tyr Gly Ala Gly Ala Gly Ser 85
90 95 Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala
Gly Ser Gly Ala Gly Ala 100 105
110 Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly
Ala 115 120 125 Gly
Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser 130
135 140 Gly Ala Ala Val Thr Gly
Arg Gly Asp Ser Pro Ala Ser Ala Ala Gly 145 150
155 160 Tyr Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala
Gly Ser Gly Ala Gly 165 170
175 Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly
180 185 190 Ala Gly
Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly 195
200 205 Ser Gly Ala Gly Ala Gly Ser
Gly Ala Ala Val Thr Gly Arg Gly Asp 210 215
220 Ser Pro Ala Ser Ala Ala Gly Tyr Gly Ala Gly Ala
Gly Ser Gly Ala 225 230 235
240 Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser
245 250 255 Gly Ala Gly
Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala 260
265 270 Gly Ser Gly Ala Gly Ala Gly Ser
Gly Ala Gly Ala Gly Ser Gly Ala 275 280
285 Ala Val Thr Gly Arg Gly Asp Ser Pro Ala Ser Ala Ala
Gly Tyr Gly 290 295 300
Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly 305
310 315 320 Ser Gly Ala Gly
Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly 325
330 335 Ala Gly Ser Gly Ala Gly Ala Gly Ser
Gly Ala Gly Ala Gly Ser Gly 340 345
350 Ala Gly Ala Gly Ser Gly Ala Ala Val Thr Gly Arg Gly Asp
Ser Pro 355 360 365
Ala Ser Ala Ala Gly Tyr Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala 370
375 380 Gly Ser Gly Ala Gly
Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala 385 390
395 400 Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser
Gly Ala Gly Ala Gly Ser 405 410
415 Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Ala
Val 420 425 430 Thr
Gly Arg Gly Asp Ser Pro Ala Ser Ala Ala Gly Tyr Gly Ala Gly 435
440 445 Ala Gly Ser Gly Ala Gly
Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly 450 455
460 Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser
Gly Ala Gly Ala Gly 465 470 475
480 Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly
485 490 495 Ala Gly
Ser Gly Ala Ala Val Thr Gly Arg Gly Asp Ser Pro Ala Ser 500
505 510 Ala Ala Gly Tyr Gly Ala Gly
Ala Gly Ser Gly Ala Gly Ala Gly Ser 515 520
525 Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser
Gly Ala Gly Ala 530 535 540
Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala 545
550 555 560 Gly Ala Gly
Ser Gly Ala Gly Ala Gly Ser Gly Ala Ala Val Thr Gly 565
570 575 Arg Gly Asp Ser Pro Ala Ser Ala
Ala Gly Tyr Gly Ala Gly Ala Gly 580 585
590 Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser
Gly Ala Gly 595 600 605
Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly 610
615 620 Ala Gly Ala Gly
Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly 625 630
635 640 Ser Gly Ala Ala Val Thr Gly Arg Gly
Asp Ser Pro Ala Ser Ala Ala 645 650
655 Gly Tyr Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser
Gly Ala 660 665 670
Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser
675 680 685 Gly Ala Gly Ala
Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala 690
695 700 Gly Ser Gly Ala Gly Ala Gly Ser
Gly Ala Ala Val Thr Gly Arg Gly 705 710
715 720 Asp Ser Pro Ala Ser Ala Ala Gly Tyr Gly Ala Gly
Ala Gly Ser Gly 725 730
735 Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly
740 745 750 Ser Gly Ala
Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly 755
760 765 Ala Gly Ser Gly Ala Gly Ala Gly
Ser Gly Ala Gly Ala Gly Ser Gly 770 775
780 Ala Ala Val Thr Gly Arg Gly Asp Ser Pro Ala Ser Ala
Ala Gly Tyr 785 790 795
800 Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala
805 810 815 Gly Ser Gly Ala
Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala 820
825 830 Gly Ala Gly Ser Gly Ala Gly Ala Gly
Ser Gly Ala Gly Ala Gly Ser 835 840
845 Gly Ala Gly Ala Gly Ser Gly Ala Ala Val Thr Gly Arg Gly
Asp Ser 850 855 860
Pro Ala Ser Ala Ala Gly Tyr Gly Ala Gly Ala Gly Ser Gly Ala Gly 865
870 875 880 Ala Gly Ser Gly Ala
Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly 885
890 895 Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly
Ser Gly Ala Gly Ala Gly 900 905
910 Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala
Ala 915 920 925 Val
Thr Gly Arg Gly Asp Ser Pro Ala Ser Ala Ala Gly Tyr Gly Ala 930
935 940 Gly Ala Gly Ser Gly Ala
Gly Ala Gly Ser Gly Ala Gly Ala Met Asp 945 950
955 960 Pro Gly Arg Tyr Gln Leu Ser Ala Gly Arg Tyr
His Tyr Gln Leu Val 965 970
975 Trp Cys Gln Lys 980 31888PRTArtificial
SequenceRepeat sequence 31Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser
Gly Ala Gly Ala 1 5 10
15 Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala
20 25 30 Gly Ala Gly
Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser 35
40 45 Gly Ala Gly Ala Gly Ser Gly Ala
Ala Pro Gly Ala Ser Ile Lys Val 50 55
60 Ala Val Ser Ala Gly Pro Ser Ala Gly Tyr Gly Ala Gly
Ala Gly Ser 65 70 75
80 Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala
85 90 95 Gly Ser Gly Ala
Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala 100
105 110 Gly Ala Gly Ser Gly Ala Gly Ala Gly
Ser Gly Ala Gly Ala Gly Ser 115 120
125 Gly Ala Ala Pro Gly Ala Ser Ile Lys Val Ala Val Ser Ala
Gly Pro 130 135 140
Ser Ala Gly Tyr Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser 145
150 155 160 Gly Ala Gly Ala Gly
Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala 165
170 175 Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala
Gly Ala Gly Ser Gly Ala 180 185
190 Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Ala Pro Gly
Ala 195 200 205 Ser
Ile Lys Val Ala Val Ser Ala Gly Pro Ser Ala Gly Tyr Gly Ala 210
215 220 Gly Ala Gly Ser Gly Ala
Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser 225 230
235 240 Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly
Ser Gly Ala Gly Ala 245 250
255 Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala
260 265 270 Gly Ala
Gly Ser Gly Ala Ala Pro Gly Ala Ser Ile Lys Val Ala Val 275
280 285 Ser Ala Gly Pro Ser Ala Gly
Tyr Gly Ala Gly Ala Gly Ser Gly Ala 290 295
300 Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala
Gly Ala Gly Ser 305 310 315
320 Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala
325 330 335 Gly Ser Gly
Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala 340
345 350 Ala Pro Gly Ala Ser Ile Lys Val
Ala Val Ser Ala Gly Pro Ser Ala 355 360
365 Gly Tyr Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly
Ser Gly Ala 370 375 380
Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser 385
390 395 400 Gly Ala Gly Ala
Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala 405
410 415 Gly Ser Gly Ala Gly Ala Gly Ser Gly
Ala Ala Pro Gly Ala Ser Ile 420 425
430 Lys Val Ala Val Ser Ala Gly Pro Ser Ala Gly Tyr Gly Ala
Gly Ala 435 440 445
Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala 450
455 460 Gly Ala Gly Ser Gly
Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser 465 470
475 480 Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala
Gly Ser Gly Ala Gly Ala 485 490
495 Gly Ser Gly Ala Ala Pro Gly Ala Ser Ile Lys Val Ala Val Ser
Ala 500 505 510 Gly
Pro Ser Ala Gly Tyr Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala 515
520 525 Gly Ser Gly Ala Gly Ala
Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala 530 535
540 Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly
Ala Gly Ala Gly Ser 545 550 555
560 Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Ala Pro
565 570 575 Gly Ala
Ser Ile Lys Val Ala Val Ser Ala Gly Pro Ser Ala Gly Tyr 580
585 590 Gly Ala Gly Ala Gly Ser Gly
Ala Gly Ala Gly Ser Gly Ala Gly Ala 595 600
605 Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala
Gly Ser Gly Ala 610 615 620
Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser 625
630 635 640 Gly Ala Gly
Ala Gly Ser Gly Ala Ala Pro Gly Ala Ser Ile Lys Val 645
650 655 Ala Val Ser Ala Gly Pro Ser Ala
Gly Tyr Gly Ala Gly Ala Gly Ser 660 665
670 Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly
Ala Gly Ala 675 680 685
Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala 690
695 700 Gly Ala Gly Ser
Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser 705 710
715 720 Gly Ala Ala Pro Gly Ala Ser Ile Lys
Val Ala Val Ser Ala Gly Pro 725 730
735 Ser Ala Gly Tyr Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala
Gly Ser 740 745 750
Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala
755 760 765 Gly Ser Gly Ala
Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala 770
775 780 Gly Ala Gly Ser Gly Ala Gly Ala
Gly Ser Gly Ala Ala Pro Gly Ala 785 790
795 800 Ser Ile Lys Val Ala Val Ser Ala Gly Pro Ser Ala
Gly Tyr Gly Ala 805 810
815 Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser
820 825 830 Gly Ala Gly
Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala 835
840 845 Gly Ser Gly Ala Gly Ala Gly Ser
Gly Ala Gly Ala Gly Ser Gly Ala 850 855
860 Gly Ala Gly Ser Gly Ala Ala Pro Gly Ala Ser Ile Lys
Val Ala Val 865 870 875
880 Ser Ala Gly Pro Ser Ala Gly Tyr 885
321019PRTArtificial SequencePronectinL 32Met Asp Pro Val Val Leu Gln Arg
Arg Asp Trp Glu Asn Pro Gly Val 1 5 10
15 Thr Gln Leu Asn Arg Leu Ala Ala His Pro Pro Phe Ala
Ser Asp Pro 20 25 30
Met Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly
35 40 45 Ser Gly Ala Gly
Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly 50
55 60 Ala Gly Ser Gly Ala Gly Ala Gly
Ser Gly Ala Ala Pro Gly Ala Ser 65 70
75 80 Ile Lys Val Ala Val Ser Ala Gly Pro Ser Ala Gly
Tyr Gly Ala Gly 85 90
95 Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly
100 105 110 Ala Gly Ala
Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly 115
120 125 Ser Gly Ala Gly Ala Gly Ser Gly
Ala Gly Ala Gly Ser Gly Ala Gly 130 135
140 Ala Gly Ser Gly Ala Ala Pro Gly Ala Ser Ile Lys Val
Ala Val Ser 145 150 155
160 Ala Gly Pro Ser Ala Gly Tyr Gly Ala Gly Ala Gly Ser Gly Ala Gly
165 170 175 Ala Gly Ser Gly
Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly 180
185 190 Ala Gly Ala Gly Ser Gly Ala Gly Ala
Gly Ser Gly Ala Gly Ala Gly 195 200
205 Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly
Ala Ala 210 215 220
Pro Gly Ala Ser Ile Lys Val Ala Val Ser Ala Gly Pro Ser Ala Gly 225
230 235 240 Tyr Gly Ala Gly Ala
Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly 245
250 255 Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly
Ala Gly Ala Gly Ser Gly 260 265
270 Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala
Gly 275 280 285 Ser
Gly Ala Gly Ala Gly Ser Gly Ala Ala Pro Gly Ala Ser Ile Lys 290
295 300 Val Ala Val Ser Ala Gly
Pro Ser Ala Gly Tyr Gly Ala Gly Ala Gly 305 310
315 320 Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala
Gly Ser Gly Ala Gly 325 330
335 Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly
340 345 350 Ala Gly
Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly 355
360 365 Ser Gly Ala Ala Pro Gly Ala
Ser Ile Lys Val Ala Val Ser Ala Gly 370 375
380 Pro Ser Ala Gly Tyr Gly Ala Gly Ala Gly Ser Gly
Ala Gly Ala Gly 385 390 395
400 Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly
405 410 415 Ala Gly Ser
Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly 420
425 430 Ala Gly Ala Gly Ser Gly Ala Gly
Ala Gly Ser Gly Ala Ala Pro Gly 435 440
445 Ala Ser Ile Lys Val Ala Val Ser Ala Gly Pro Ser Ala
Gly Tyr Gly 450 455 460
Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly 465
470 475 480 Ser Gly Ala Gly
Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly 485
490 495 Ala Gly Ser Gly Ala Gly Ala Gly Ser
Gly Ala Gly Ala Gly Ser Gly 500 505
510 Ala Gly Ala Gly Ser Gly Ala Ala Pro Gly Ala Ser Ile Lys
Val Ala 515 520 525
Val Ser Ala Gly Pro Ser Ala Gly Tyr Gly Ala Gly Ala Gly Ser Gly 530
535 540 Ala Gly Ala Gly Ser
Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly 545 550
555 560 Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly
Ala Gly Ser Gly Ala Gly 565 570
575 Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser
Gly 580 585 590 Ala
Ala Pro Gly Ala Ser Ile Lys Val Ala Val Ser Ala Gly Pro Ser 595
600 605 Ala Gly Tyr Gly Ala Gly
Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly 610 615
620 Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser
Gly Ala Gly Ala Gly 625 630 635
640 Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly
645 650 655 Ala Gly
Ser Gly Ala Gly Ala Gly Ser Gly Ala Ala Pro Gly Ala Ser 660
665 670 Ile Lys Val Ala Val Ser Ala
Gly Pro Ser Ala Gly Tyr Gly Ala Gly 675 680
685 Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly
Ala Gly Ser Gly 690 695 700
Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly 705
710 715 720 Ser Gly Ala
Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly 725
730 735 Ala Gly Ser Gly Ala Ala Pro Gly
Ala Ser Ile Lys Val Ala Val Ser 740 745
750 Ala Gly Pro Ser Ala Gly Tyr Gly Ala Gly Ala Gly Ser
Gly Ala Gly 755 760 765
Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly 770
775 780 Ala Gly Ala Gly
Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly 785 790
795 800 Ser Gly Ala Gly Ala Gly Ser Gly Ala
Gly Ala Gly Ser Gly Ala Ala 805 810
815 Pro Gly Ala Ser Ile Lys Val Ala Val Ser Ala Gly Pro Ser
Ala Gly 820 825 830
Tyr Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly
835 840 845 Ala Gly Ser Gly
Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly 850
855 860 Ala Gly Ala Gly Ser Gly Ala Gly
Ala Gly Ser Gly Ala Gly Ala Gly 865 870
875 880 Ser Gly Ala Gly Ala Gly Ser Gly Ala Ala Pro Gly
Ala Ser Ile Lys 885 890
895 Val Ala Val Ser Ala Gly Pro Ser Ala Gly Tyr Gly Ala Gly Ala Gly
900 905 910 Ser Gly Ala
Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala Gly 915
920 925 Ala Gly Ser Gly Ala Gly Ala Gly
Ser Gly Ala Gly Ala Gly Ser Gly 930 935
940 Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly Ser Gly Ala
Gly Ala Gly 945 950 955
960 Ser Gly Ala Ala Pro Gly Ala Ser Ile Lys Val Ala Val Ser Ala Gly
965 970 975 Pro Ser Ala Gly
Tyr Gly Ala Gly Ala Gly Ser Gly Ala Gly Ala Gly 980
985 990 Ser Gly Ala Gly Ala Met Asp Pro
Gly Arg Tyr Gln Leu Ser Ala Gly 995 1000
1005 Arg Tyr His Tyr Gln Leu Val Trp Cys Gln Lys
1010 1015 33436PRTOryctolagus cuniculus
33Met Asp Pro Met Leu Thr Gln Thr Pro Ala Ser Val Ser Ala Ala Val 1
5 10 15 Gly Gly Thr Val
Thr Ile Lys Cys Gln Ala Ser Glu Asn Ile Tyr Thr 20
25 30 Ser Leu Ala Trp Tyr Gln Gln Lys Pro
Gly His Ser Pro Lys Leu Leu 35 40
45 Ile Tyr Ser Ala Ser Thr Leu Ala Ser Gly Val Ala Ser Arg
Phe Lys 50 55 60
Gly Ser Gly Ser Gly Thr Gln Phe Thr Leu Thr Ile Ser Gly Val Gln 65
70 75 80 Cys Asp Asp Ala Ala
Thr Tyr Tyr Cys Gln Cys Ser Ala Tyr Gly Arg 85
90 95 Ser Gly Asn Ser Phe Gly Gly Gly Thr Glu
Val Val Val Asn Gly Asp 100 105
110 Pro Val Ala Pro Thr Val Leu Ile Phe Pro Pro Ala Ala Asp Gln
Val 115 120 125 Ala
Thr Gly Thr Val Thr Ile Val Cys Val Ala Asn Lys Tyr Phe Pro 130
135 140 Asp Val Thr Val Thr Trp
Glu Val Asp Gly Thr Thr Gln Thr Thr Gly 145 150
155 160 Ile Glu Asn Ser Lys Thr Pro Gln Asn Ser Ala
Asp Cys Thr Tyr Asn 165 170
175 Leu Ser Ser Thr Leu Thr Leu Thr Ser Thr Gln Tyr Asn Ser His Lys
180 185 190 Glu Tyr
Thr Cys Lys Val Thr Gln Gly Thr Thr Ser Val Val Gln Ser 195
200 205 Phe Asn Arg Gly Asp Cys Met
Gln Ser Leu Glu Glu Ser Gly Gly Arg 210 215
220 Leu Val Thr Pro Gly Thr Pro Leu Thr Leu Thr Cys
Thr Val Ser Gly 225 230 235
240 Ile Asp Leu Ser Arg Tyr Ala Met Gly Trp Val Arg Gln Ala Pro Gly
245 250 255 Lys Gly Leu
Glu Trp Ile Ala Met Ile Asn Gly Tyr Gly Thr Thr Tyr 260
265 270 Tyr Ala Ser Trp Ala Lys Gly Arg
Phe Thr Ile Ser Arg Thr Ser Thr 275 280
285 Thr Val Asp Leu Lys Ile Thr Ser Pro Thr Thr Glu Asp
Thr Ala Thr 290 295 300
Tyr Phe Cys Val Arg Tyr Pro Glu Ser Ser Ser Met Phe Asp Leu Trp 305
310 315 320 Gly Gln Gly Thr
Leu Val Thr Val Ser Ser Gly Gln Pro Lys Ala Pro 325
330 335 Ser Val Phe Pro Leu Ala Pro Cys Cys
Gly Asp Thr Pro Ser Ser Thr 340 345
350 Val Thr Leu Gly Cys Leu Val Lys Gly Tyr Leu Pro Glu Pro
Val Thr 355 360 365
Val Thr Trp Asn Ser Gly Thr Leu Thr Asn Gly Val Arg Thr Phe Pro 370
375 380 Ser Val Arg Gln Ser
Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Ser 385 390
395 400 Val Thr Ser Ser Ser Gln Pro Val Thr Cys
Asn Val Ala His Pro Ala 405 410
415 Thr Asn Thr Lys Val Asp Lys Thr Val Ala Pro Ser Thr Cys Ser
Lys 420 425 430 Pro
Thr Cys Pro 435 34605PRTAspergillus niger 34Met Gln Thr Leu
Leu Val Ser Ser Leu Val Val Ser Leu Ala Ala Ala 1 5
10 15 Leu Pro His Tyr Ile Arg Ser Asn Gly
Ile Glu Ala Ser Leu Leu Thr 20 25
30 Asp Pro Lys Asp Val Ser Gly Arg Thr Val Asp Tyr Ile Ile
Ala Gly 35 40 45
Gly Gly Leu Thr Gly Leu Thr Thr Ala Ala Arg Leu Thr Glu Asn Pro 50
55 60 Asn Ile Ser Val Leu
Val Ile Glu Ser Gly Ser Tyr Glu Ser Asp Arg 65 70
75 80 Gly Pro Ile Ile Glu Asp Leu Asn Ala Tyr
Gly Asp Ile Phe Gly Ser 85 90
95 Ser Val Asp His Ala Tyr Glu Thr Val Glu Leu Ala Thr Asn Asn
Gln 100 105 110 Thr
Ala Leu Ile Arg Ser Gly Asn Gly Leu Gly Gly Ser Thr Leu Val 115
120 125 Asn Gly Gly Thr Trp Thr
Arg Pro His Lys Ala Gln Val Asp Ser Trp 130 135
140 Glu Thr Val Phe Gly Asn Glu Gly Trp Asn Trp
Asp Asn Val Ala Ala 145 150 155
160 Tyr Ser Leu Gln Ala Glu Arg Ala Arg Ala Pro Asn Ala Lys Gln Ile
165 170 175 Ala Ala
Gly His Tyr Phe Asn Ala Ser Cys His Gly Val Asn Gly Thr 180
185 190 Val His Ala Gly Pro Arg Asp
Thr Gly Asp Asp Tyr Ser Pro Ile Val 195 200
205 Lys Ala Leu Met Ser Ala Val Glu Asp Arg Gly Val
Pro Thr Lys Lys 210 215 220
Asp Phe Gly Cys Gly Asp Pro His Gly Val Ser Met Phe Pro Asn Thr 225
230 235 240 Leu His Glu
Asp Gln Val Arg Ser Asp Ala Ala Arg Glu Trp Leu Leu 245
250 255 Pro Asn Tyr Gln Arg Pro Asn Leu
Gln Val Leu Thr Gly Gln Tyr Val 260 265
270 Gly Lys Val Leu Leu Ser Gln Asn Gly Thr Thr Pro Arg
Ala Val Gly 275 280 285
Val Glu Phe Gly Thr His Lys Gly Asn Thr His Asn Val Tyr Ala Lys 290
295 300 His Glu Val Leu
Leu Ala Ala Gly Ser Ala Val Ser Pro Thr Ile Leu 305 310
315 320 Glu Tyr Ser Gly Ile Gly Met Lys Ser
Ile Leu Glu Pro Leu Gly Ile 325 330
335 Asp Thr Val Val Asp Leu Pro Val Gly Leu Asn Leu Gln Asp
Gln Thr 340 345 350
Thr Ala Thr Val Arg Ser Arg Ile Thr Ser Ala Gly Ala Gly Gln Gly
355 360 365 Gln Ala Ala Trp
Phe Ala Thr Phe Asn Glu Thr Phe Gly Asp Tyr Ser 370
375 380 Glu Lys Ala His Glu Leu Leu Asn
Thr Lys Leu Glu Gln Trp Ala Glu 385 390
395 400 Glu Ala Val Ala Arg Gly Gly Phe His Asn Thr Thr
Ala Leu Leu Ile 405 410
415 Gln Tyr Glu Asn Tyr Arg Asp Trp Ile Val Asn His Asn Val Ala Tyr
420 425 430 Ser Glu Leu
Phe Leu Asp Thr Ala Gly Val Ala Ser Phe Asp Val Trp 435
440 445 Asp Leu Leu Pro Phe Thr Arg Gly
Tyr Val His Ile Leu Asp Lys Asp 450 455
460 Pro Tyr Leu His His Phe Ala Tyr Asp Pro Gln Tyr Phe
Leu Asn Glu 465 470 475
480 Leu Asp Leu Leu Gly Gln Ala Ala Ala Thr Gln Leu Ala Arg Asn Ile
485 490 495 Ser Asn Ser Gly
Ala Met Gln Thr Tyr Phe Ala Gly Glu Thr Ile Pro 500
505 510 Gly Asp Asn Leu Ala Tyr Asp Ala Asp
Leu Ser Ala Trp Thr Glu Tyr 515 520
525 Ile Pro Tyr His Phe Arg Pro Asn Tyr His Gly Val Gly Thr
Cys Ser 530 535 540
Met Met Pro Lys Glu Met Gly Gly Val Val Asp Asn Ala Ala Arg Val 545
550 555 560 Tyr Gly Val Gln Gly
Leu Arg Val Ile Asp Gly Ser Ile Pro Pro Thr 565
570 575 Gln Met Ser Ser His Val Met Thr Val Phe
Tyr Ala Met Ala Leu Lys 580 585
590 Ile Ser Asp Ala Ile Leu Glu Asp Tyr Ala Ser Met Gln
595 600 605 35607PRTBos taurus 35Met Lys
Trp Val Thr Phe Ile Ser Leu Leu Leu Leu Phe Ser Ser Ala 1 5
10 15 Tyr Ser Arg Gly Val Phe Arg
Arg Asp Thr His Lys Ser Glu Ile Ala 20 25
30 His Arg Phe Lys Asp Leu Gly Glu Glu His Phe Lys
Gly Leu Val Leu 35 40 45
Ile Ala Phe Ser Gln Tyr Leu Gln Gln Cys Pro Phe Asp Glu His Val
50 55 60 Lys Leu Val
Asn Glu Leu Thr Glu Phe Ala Lys Thr Cys Val Ala Asp 65
70 75 80 Glu Ser His Ala Gly Cys Glu
Lys Ser Leu His Thr Leu Phe Gly Asp 85
90 95 Glu Leu Cys Lys Val Ala Ser Leu Arg Glu Thr
Tyr Gly Asp Met Ala 100 105
110 Asp Cys Cys Glu Lys Gln Glu Pro Glu Arg Asn Glu Cys Phe Leu
Ser 115 120 125 His
Lys Asp Asp Ser Pro Asp Leu Pro Lys Leu Lys Pro Asp Pro Asn 130
135 140 Thr Leu Cys Asp Glu Phe
Lys Ala Asp Glu Lys Lys Phe Trp Gly Lys 145 150
155 160 Tyr Leu Tyr Glu Ile Ala Arg Arg His Pro Tyr
Phe Tyr Ala Pro Glu 165 170
175 Leu Leu Tyr Tyr Ala Asn Lys Tyr Asn Gly Val Phe Gln Glu Cys Cys
180 185 190 Gln Ala
Glu Asp Lys Gly Ala Cys Leu Leu Pro Lys Ile Glu Thr Met 195
200 205 Arg Glu Lys Val Leu Ala Ser
Ser Ala Arg Gln Arg Leu Arg Cys Ala 210 215
220 Ser Ile Gln Lys Phe Gly Glu Arg Ala Leu Lys Ala
Trp Ser Val Ala 225 230 235
240 Arg Leu Ser Gln Lys Phe Pro Lys Ala Glu Phe Val Glu Val Thr Lys
245 250 255 Leu Val Thr
Asp Leu Thr Lys Val His Lys Glu Cys Cys His Gly Asp 260
265 270 Leu Leu Glu Cys Ala Asp Asp Arg
Ala Asp Leu Ala Lys Tyr Ile Cys 275 280
285 Asp Asn Gln Asp Thr Ile Ser Ser Lys Leu Lys Glu Cys
Cys Asp Lys 290 295 300
Pro Leu Leu Glu Lys Ser His Cys Ile Ala Glu Val Glu Lys Asp Ala 305
310 315 320 Ile Pro Glu Asn
Leu Pro Pro Leu Thr Ala Asp Phe Ala Glu Asp Lys 325
330 335 Asp Val Cys Lys Asn Tyr Gln Glu Ala
Lys Asp Ala Phe Leu Gly Ser 340 345
350 Phe Leu Tyr Glu Tyr Ser Arg Arg His Pro Glu Tyr Ala Val
Ser Val 355 360 365
Leu Leu Arg Leu Ala Lys Glu Tyr Glu Ala Thr Leu Glu Glu Cys Cys 370
375 380 Ala Lys Asp Asp Pro
His Ala Cys Tyr Ser Thr Val Phe Asp Lys Leu 385 390
395 400 Lys His Leu Val Asp Glu Pro Gln Asn Leu
Ile Lys Gln Asn Cys Asp 405 410
415 Gln Phe Glu Lys Leu Gly Glu Tyr Gly Phe Gln Asn Ala Leu Ile
Val 420 425 430 Arg
Tyr Thr Arg Lys Val Pro Gln Val Ser Thr Pro Thr Leu Val Glu 435
440 445 Val Ser Arg Ser Leu Gly
Lys Val Gly Thr Arg Cys Cys Thr Lys Pro 450 455
460 Glu Ser Glu Arg Met Pro Cys Thr Glu Asp Tyr
Leu Ser Leu Ile Leu 465 470 475
480 Asn Arg Leu Cys Val Leu His Glu Lys Thr Pro Val Ser Glu Lys Val
485 490 495 Thr Lys
Cys Cys Thr Glu Ser Leu Val Asn Arg Arg Pro Cys Phe Ser 500
505 510 Ala Leu Thr Pro Asp Glu Thr
Tyr Val Pro Lys Ala Phe Asp Glu Lys 515 520
525 Leu Phe Thr Phe His Ala Asp Ile Cys Thr Leu Pro
Asp Thr Glu Lys 530 535 540
Gln Ile Lys Lys Gln Thr Ala Leu Val Glu Leu Leu Lys His Lys Pro 545
550 555 560 Lys Ala Thr
Glu Glu Gln Leu Lys Thr Val Met Glu Asn Phe Val Ala 565
570 575 Phe Val Asp Lys Cys Cys Ala Ala
Asp Asp Lys Glu Ala Cys Phe Ala 580 585
590 Val Glu Gly Pro Lys Leu Val Val Ser Thr Gln Thr Ala
Leu Ala 595 600 605
User Contributions:
Comment about this patent or add new information about this topic: